IL292355A - הרכבים ושיטות להפעלה והרחבה חוץ גופית של אוכלוסיות תא t הורג סדרתי וחיסון פסיבי של חולה סרטן עם תאים הורגים תאי גידול - Google Patents

Info

Publication number

IL292355A

IL292355A IL292355A IL29235522A IL292355A IL 292355 A IL292355 A IL 292355A IL 292355 A IL292355 A IL 292355A IL 29235522 A IL29235522 A IL 29235522A IL 292355 A IL292355 A IL 292355A

Authority

IL

Israel

Prior art keywords

cells

cell

tumor

immune

cancer

Prior art date

2019-10-22

Links

• Espacenet
• Global Dossier
• Discuss

• 210000004027 cell Anatomy 0.000 title claims 524
• 206010028980 Neoplasm Diseases 0.000 title claims 193
• 238000000034 method Methods 0.000 title claims 77
• 201000011510 cancer Diseases 0.000 title claims 71
• 210000004881 tumor cell Anatomy 0.000 title claims 67
• 230000004913 activation Effects 0.000 title claims 65
• 238000000338 in vitro Methods 0.000 title claims 31
• 239000000203 mixture Substances 0.000 title claims 26
• 230000003053 immunization Effects 0.000 title claims 11
• 238000002649 immunization Methods 0.000 title claims 11
• 210000001239 CD8-positive, alpha-beta cytotoxic T lymphocyte Anatomy 0.000 title claims 5
• 230000022534 cell killing Effects 0.000 title claims 5
• 210000001744 T-lymphocyte Anatomy 0.000 claims 197
• 239000000427 antigen Substances 0.000 claims 137
• 102000036639 antigens Human genes 0.000 claims 128
• 108091007433 antigens Proteins 0.000 claims 128
• 108090000623 proteins and genes Proteins 0.000 claims 92
• 210000005087 mononuclear cell Anatomy 0.000 claims 75
• 108090000765 processed proteins & peptides Proteins 0.000 claims 75
• 210000000822 natural killer cell Anatomy 0.000 claims 69
• 102000005962 receptors Human genes 0.000 claims 68
• 108020003175 receptors Proteins 0.000 claims 68
• 238000001994 activation Methods 0.000 claims 67
• 230000014509 gene expression Effects 0.000 claims 67
• 102000004127 Cytokines Human genes 0.000 claims 65
• 108090000695 Cytokines Proteins 0.000 claims 65
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 64
• 239000003446 ligand Substances 0.000 claims 63
• 102000004169 proteins and genes Human genes 0.000 claims 63
• 239000013598 vector Substances 0.000 claims 62
• 210000003719 b-lymphocyte Anatomy 0.000 claims 61
• 235000018102 proteins Nutrition 0.000 claims 61
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 claims 60
• 230000006870 function Effects 0.000 claims 57
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims 56
• 108091008874 T cell receptors Proteins 0.000 claims 55
• 230000028993 immune response Effects 0.000 claims 51
• 210000004443 dendritic cell Anatomy 0.000 claims 50
• 210000000987 immune system Anatomy 0.000 claims 50
• 210000004698 lymphocyte Anatomy 0.000 claims 50
• 239000000047 product Substances 0.000 claims 50
• 210000000581 natural killer T-cell Anatomy 0.000 claims 49
• 241000282414 Homo sapiens Species 0.000 claims 48
• MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 46
• 210000000612 antigen-presenting cell Anatomy 0.000 claims 44
• 239000012636 effector Substances 0.000 claims 44
• 102000004196 processed proteins & peptides Human genes 0.000 claims 44
• 239000003814 drug Substances 0.000 claims 43
• 230000004044 response Effects 0.000 claims 43
• 230000008569 process Effects 0.000 claims 42
• 108700018351 Major Histocompatibility Complex Proteins 0.000 claims 38
• 230000001472 cytotoxic effect Effects 0.000 claims 38
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 37
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 claims 37
• 230000001225 therapeutic effect Effects 0.000 claims 37
• 210000001519 tissue Anatomy 0.000 claims 36
• 229940079593 drug Drugs 0.000 claims 35
• 230000036039 immunity Effects 0.000 claims 35
• 230000007246 mechanism Effects 0.000 claims 33
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims 32
• 231100000433 cytotoxic Toxicity 0.000 claims 31
• 210000000265 leukocyte Anatomy 0.000 claims 31
• 230000001404 mediated effect Effects 0.000 claims 31
• 210000001616 monocyte Anatomy 0.000 claims 31
• 230000000694 effects Effects 0.000 claims 30
• 230000006698 induction Effects 0.000 claims 27
• 210000002540 macrophage Anatomy 0.000 claims 27
• 210000004985 myeloid-derived suppressor cell Anatomy 0.000 claims 27
• 244000052769 pathogen Species 0.000 claims 27
• 230000037361 pathway Effects 0.000 claims 27
• -1 IL-10 Proteins 0.000 claims 26
• 230000000735 allogeneic effect Effects 0.000 claims 26
• 230000001419 dependent effect Effects 0.000 claims 26
• 230000003993 interaction Effects 0.000 claims 26
• 239000002773 nucleotide Substances 0.000 claims 25
• 125000003729 nucleotide group Chemical group 0.000 claims 25
• 238000004519 manufacturing process Methods 0.000 claims 24
• 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 claims 23
• 201000010099 disease Diseases 0.000 claims 23
• 239000000126 substance Substances 0.000 claims 23
• 125000003275 alpha amino acid group Chemical group 0.000 claims 22
• 235000001014 amino acid Nutrition 0.000 claims 22
• 238000001565 modulated differential scanning calorimetry Methods 0.000 claims 22
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims 21
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims 21
• 229940024606 amino acid Drugs 0.000 claims 21
• 150000001413 amino acids Chemical class 0.000 claims 21
• 210000002865 immune cell Anatomy 0.000 claims 21
• 150000007523 nucleic acids Chemical group 0.000 claims 21
• 108010042215 OX40 Ligand Proteins 0.000 claims 20
• 102100026890 Tumor necrosis factor ligand superfamily member 4 Human genes 0.000 claims 20
• 230000001461 cytolytic effect Effects 0.000 claims 20
• 210000002443 helper t lymphocyte Anatomy 0.000 claims 20
• 230000002519 immonomodulatory effect Effects 0.000 claims 20
• 150000003839 salts Chemical class 0.000 claims 20
• 210000004981 tumor-associated macrophage Anatomy 0.000 claims 20
• 102000007499 CD27 Ligand Human genes 0.000 claims 19
• 108010046080 CD27 Ligand Proteins 0.000 claims 19
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims 19
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims 19
• 102000019034 Chemokines Human genes 0.000 claims 19
• 108010012236 Chemokines Proteins 0.000 claims 19
• 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 claims 19
• 241000282412 Homo Species 0.000 claims 18
• 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 claims 18
• 108010002350 Interleukin-2 Proteins 0.000 claims 18
• 102000000588 Interleukin-2 Human genes 0.000 claims 18
• 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 claims 18
• 108010056995 Perforin Proteins 0.000 claims 18
• 102000004503 Perforin Human genes 0.000 claims 18
• 230000001965 increasing effect Effects 0.000 claims 18
• 239000011886 peripheral blood Substances 0.000 claims 18
• 229920001184 polypeptide Polymers 0.000 claims 18
• 230000001105 regulatory effect Effects 0.000 claims 18
• 241000699666 Mus <mouse, genus> Species 0.000 claims 17
• KHGNFPUMBJSZSM-UHFFFAOYSA-N Perforine Natural products COC1=C2CCC(O)C(CCC(C)(C)O)(OC)C2=NC2=C1C=CO2 KHGNFPUMBJSZSM-UHFFFAOYSA-N 0.000 claims 17
• 230000003213 activating effect Effects 0.000 claims 17
• 230000006907 apoptotic process Effects 0.000 claims 17
• 239000012472 biological sample Substances 0.000 claims 17
• 210000004369 blood Anatomy 0.000 claims 17
• 239000008280 blood Substances 0.000 claims 17
• 210000001185 bone marrow Anatomy 0.000 claims 17
• 239000002955 immunomodulating agent Substances 0.000 claims 17
• 229940121354 immunomodulator Drugs 0.000 claims 17
• 230000001506 immunosuppresive effect Effects 0.000 claims 17
• 230000001939 inductive effect Effects 0.000 claims 17
• 102000039446 nucleic acids Human genes 0.000 claims 17
• 108020004707 nucleic acids Proteins 0.000 claims 17
• 229930192851 perforin Natural products 0.000 claims 17
• 210000005259 peripheral blood Anatomy 0.000 claims 17
• 238000011282 treatment Methods 0.000 claims 17
• 241000699670 Mus sp. Species 0.000 claims 16
• 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 claims 16
• 101710097160 Tumor necrosis factor ligand superfamily member 10 Proteins 0.000 claims 16
• 230000000139 costimulatory effect Effects 0.000 claims 16
• 230000002401 inhibitory effect Effects 0.000 claims 16
• 239000012528 membrane Substances 0.000 claims 16
• 230000001717 pathogenic effect Effects 0.000 claims 16
• 108020004705 Codon Proteins 0.000 claims 15
• 102000001398 Granzyme Human genes 0.000 claims 15
• 108060005986 Granzyme Proteins 0.000 claims 15
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims 15
• 102000037982 Immune checkpoint proteins Human genes 0.000 claims 15
• 108091008036 Immune checkpoint proteins Proteins 0.000 claims 15
• 108091054437 MHC class I family Proteins 0.000 claims 15
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims 15
• 210000004405 cytokine-induced killer cell Anatomy 0.000 claims 15
• 238000011161 development Methods 0.000 claims 15
• 230000018109 developmental process Effects 0.000 claims 15
• 230000004069 differentiation Effects 0.000 claims 15
• 108010029697 CD40 Ligand Proteins 0.000 claims 14
• 102100032937 CD40 ligand Human genes 0.000 claims 14
• 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims 14
• 102100020862 Lymphocyte activation gene 3 protein Human genes 0.000 claims 14
• 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 14
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 14
• 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 claims 14
• 108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 claims 14
• 208000035475 disorder Diseases 0.000 claims 14
• 210000003958 hematopoietic stem cell Anatomy 0.000 claims 14
• 230000002147 killing effect Effects 0.000 claims 14
• 239000003550 marker Substances 0.000 claims 14
• 102100029740 Poliovirus receptor Human genes 0.000 claims 13
• 102000002689 Toll-like receptor Human genes 0.000 claims 13
• 108020000411 Toll-like receptor Proteins 0.000 claims 13
• 238000003556 assay Methods 0.000 claims 13
• 230000033228 biological regulation Effects 0.000 claims 13
• 238000011160 research Methods 0.000 claims 13
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 12
• 102000043129 MHC class I family Human genes 0.000 claims 12
• 231100000135 cytotoxicity Toxicity 0.000 claims 12
• 230000003013 cytotoxicity Effects 0.000 claims 12
• 230000002093 peripheral effect Effects 0.000 claims 12
• 239000012071 phase Substances 0.000 claims 12
• 230000000770 proinflammatory effect Effects 0.000 claims 12
• 210000003289 regulatory T cell Anatomy 0.000 claims 12
• 230000028327 secretion Effects 0.000 claims 12
• 230000000638 stimulation Effects 0.000 claims 12
• 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 11
• 102000004388 Interleukin-4 Human genes 0.000 claims 11
• 108090000978 Interleukin-4 Proteins 0.000 claims 11
• 230000000259 anti-tumor effect Effects 0.000 claims 11
• 230000001413 cellular effect Effects 0.000 claims 11
• 238000000684 flow cytometry Methods 0.000 claims 11
• 208000015181 infectious disease Diseases 0.000 claims 11
• 230000003834 intracellular effect Effects 0.000 claims 11
• 210000001541 thymus gland Anatomy 0.000 claims 11
• 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 claims 11
• 101100044298 Drosophila melanogaster fand gene Proteins 0.000 claims 10
• 101150064015 FAS gene Proteins 0.000 claims 10
• 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 claims 10
• 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 claims 10
• 102100022338 Integrin alpha-M Human genes 0.000 claims 10
• 102000013462 Interleukin-12 Human genes 0.000 claims 10
• 108010065805 Interleukin-12 Proteins 0.000 claims 10
• 101100335198 Pneumocystis carinii fol1 gene Proteins 0.000 claims 10
• 229940126547 T-cell immunoglobulin mucin-3 Drugs 0.000 claims 10
• 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 claims 10
• 230000009471 action Effects 0.000 claims 10
• 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 claims 10
• 239000000872 buffer Substances 0.000 claims 10
• 230000030833 cell death Effects 0.000 claims 10
• 230000009089 cytolysis Effects 0.000 claims 10
• 210000004700 fetal blood Anatomy 0.000 claims 10
• 230000015788 innate immune response Effects 0.000 claims 10
• 210000001165 lymph node Anatomy 0.000 claims 10
• 239000000463 material Substances 0.000 claims 10
• 230000035800 maturation Effects 0.000 claims 10
• 230000011664 signaling Effects 0.000 claims 10
• 108020004414 DNA Proteins 0.000 claims 9
• 108091028043 Nucleic acid sequence Proteins 0.000 claims 9
• 230000030741 antigen processing and presentation Effects 0.000 claims 9
• 230000000890 antigenic effect Effects 0.000 claims 9
• 210000000170 cell membrane Anatomy 0.000 claims 9
• 238000006243 chemical reaction Methods 0.000 claims 9
• 230000008030 elimination Effects 0.000 claims 9
• 238000003379 elimination reaction Methods 0.000 claims 9
• 230000002163 immunogen Effects 0.000 claims 9
• 108091008042 inhibitory receptors Proteins 0.000 claims 9
• 229940117681 interleukin-12 Drugs 0.000 claims 9
• 229940028885 interleukin-4 Drugs 0.000 claims 9
• 108010048507 poliovirus receptor Proteins 0.000 claims 9
• 102000040430 polynucleotide Human genes 0.000 claims 9
• 108091033319 polynucleotide Proteins 0.000 claims 9
• 239000002157 polynucleotide Substances 0.000 claims 9
• 239000002243 precursor Substances 0.000 claims 9
• 241000894007 species Species 0.000 claims 9
• 238000006467 substitution reaction Methods 0.000 claims 9
• 230000004083 survival effect Effects 0.000 claims 9
• 230000001988 toxicity Effects 0.000 claims 9
• 231100000419 toxicity Toxicity 0.000 claims 9
• 230000003844 B-cell-activation Effects 0.000 claims 8
• 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims 8
• 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims 8
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims 8
• 108060003951 Immunoglobulin Proteins 0.000 claims 8
• 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 claims 8
• 230000005867 T cell response Effects 0.000 claims 8
• 230000004721 adaptive immunity Effects 0.000 claims 8
• 238000007792 addition Methods 0.000 claims 8
• 230000008901 benefit Effects 0.000 claims 8
• 238000004422 calculation algorithm Methods 0.000 claims 8
• 230000002068 genetic effect Effects 0.000 claims 8
• 230000013632 homeostatic process Effects 0.000 claims 8
• 102000018358 immunoglobulin Human genes 0.000 claims 8
• 238000009169 immunotherapy Methods 0.000 claims 8
• 150000002632 lipids Chemical class 0.000 claims 8
• 244000005700 microbiome Species 0.000 claims 8
• 210000000066 myeloid cell Anatomy 0.000 claims 8
• 239000008194 pharmaceutical composition Substances 0.000 claims 8
• 230000003389 potentiating effect Effects 0.000 claims 8
• 210000000952 spleen Anatomy 0.000 claims 8
• 230000005751 tumor progression Effects 0.000 claims 8
• 229930186217 Glycolipid Natural products 0.000 claims 7
• 101710083479 Hepatitis A virus cellular receptor 2 homolog Proteins 0.000 claims 7
• 206010061309 Neoplasm progression Diseases 0.000 claims 7
• 108020004511 Recombinant DNA Proteins 0.000 claims 7
• 239000013543 active substance Substances 0.000 claims 7
• 230000008859 change Effects 0.000 claims 7
• 230000000295 complement effect Effects 0.000 claims 7
• 230000007123 defense Effects 0.000 claims 7
• 239000000975 dye Substances 0.000 claims 7
• 230000001900 immune effect Effects 0.000 claims 7
• 230000002584 immunomodulator Effects 0.000 claims 7
• 230000004957 immunoregulator effect Effects 0.000 claims 7
• 230000002757 inflammatory effect Effects 0.000 claims 7
• 210000003810 lymphokine-activated killer cell Anatomy 0.000 claims 7
• 210000003071 memory t lymphocyte Anatomy 0.000 claims 7
• 238000007799 mixed lymphocyte reaction assay Methods 0.000 claims 7
• 230000008520 organization Effects 0.000 claims 7
• 230000035755 proliferation Effects 0.000 claims 7
• 230000019491 signal transduction Effects 0.000 claims 7
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 7
• 229960005486 vaccine Drugs 0.000 claims 7
• 102100038077 CD226 antigen Human genes 0.000 claims 6
• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims 6
• 102000004190 Enzymes Human genes 0.000 claims 6
• 108090000790 Enzymes Proteins 0.000 claims 6
• 101000884298 Homo sapiens CD226 antigen Proteins 0.000 claims 6
• 101000589305 Homo sapiens Natural cytotoxicity triggering receptor 2 Proteins 0.000 claims 6
• 108010002616 Interleukin-5 Proteins 0.000 claims 6
• 102000015696 Interleukins Human genes 0.000 claims 6
• 108010063738 Interleukins Proteins 0.000 claims 6
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 6
• 102100032851 Natural cytotoxicity triggering receptor 2 Human genes 0.000 claims 6
• 102100032852 Natural cytotoxicity triggering receptor 3 Human genes 0.000 claims 6
• 206010057249 Phagocytosis Diseases 0.000 claims 6
• 239000002253 acid Substances 0.000 claims 6
• 125000000539 amino acid group Chemical group 0.000 claims 6
• 238000002619 cancer immunotherapy Methods 0.000 claims 6
• 230000024245 cell differentiation Effects 0.000 claims 6
• 230000003915 cell function Effects 0.000 claims 6
• 239000003153 chemical reaction reagent Substances 0.000 claims 6
• 150000001875 compounds Chemical class 0.000 claims 6
• 238000012258 culturing Methods 0.000 claims 6
• 238000012217 deletion Methods 0.000 claims 6
• 230000037430 deletion Effects 0.000 claims 6
• 238000001514 detection method Methods 0.000 claims 6
• 239000003937 drug carrier Substances 0.000 claims 6
• 229940088598 enzyme Drugs 0.000 claims 6
• 238000001943 fluorescence-activated cell sorting Methods 0.000 claims 6
• 230000036541 health Effects 0.000 claims 6
• 230000008629 immune suppression Effects 0.000 claims 6
• 230000000977 initiatory effect Effects 0.000 claims 6
• 238000002347 injection Methods 0.000 claims 6
• 239000007924 injection Substances 0.000 claims 6
• 210000003563 lymphoid tissue Anatomy 0.000 claims 6
• 102000007863 pattern recognition receptors Human genes 0.000 claims 6
• 108010089193 pattern recognition receptors Proteins 0.000 claims 6
• 239000008188 pellet Substances 0.000 claims 6
• 230000008782 phagocytosis Effects 0.000 claims 6
• 210000000130 stem cell Anatomy 0.000 claims 6
• 239000006228 supernatant Substances 0.000 claims 6
• 208000024891 symptom Diseases 0.000 claims 6
• 238000012546 transfer Methods 0.000 claims 6
• 241000894006 Bacteria Species 0.000 claims 5
• 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 claims 5
• 101000916644 Homo sapiens Macrophage colony-stimulating factor 1 receptor Proteins 0.000 claims 5
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims 5
• 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 claims 5
• 101000635938 Homo sapiens Transforming growth factor beta-1 proprotein Proteins 0.000 claims 5
• 102000000589 Interleukin-1 Human genes 0.000 claims 5
• 108010002352 Interleukin-1 Proteins 0.000 claims 5
• 108090000176 Interleukin-13 Proteins 0.000 claims 5
• 102000003816 Interleukin-13 Human genes 0.000 claims 5
• 108090000172 Interleukin-15 Proteins 0.000 claims 5
• 102000003812 Interleukin-15 Human genes 0.000 claims 5
• 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 claims 5
• 241001465754 Metazoa Species 0.000 claims 5
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims 5
• 102100032870 Natural cytotoxicity triggering receptor 1 Human genes 0.000 claims 5
• 102100035488 Nectin-2 Human genes 0.000 claims 5
• 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 claims 5
• 108700008625 Reporter Genes Proteins 0.000 claims 5
• 230000024932 T cell mediated immunity Effects 0.000 claims 5
• 102100030742 Transforming growth factor beta-1 proprotein Human genes 0.000 claims 5
• 241000700605 Viruses Species 0.000 claims 5
• 230000003044 adaptive effect Effects 0.000 claims 5
• 230000033289 adaptive immune response Effects 0.000 claims 5
• 230000033115 angiogenesis Effects 0.000 claims 5
• 230000000118 anti-neoplastic effect Effects 0.000 claims 5
• 239000002585 base Substances 0.000 claims 5
• 230000015572 biosynthetic process Effects 0.000 claims 5
• 210000001772 blood platelet Anatomy 0.000 claims 5
• 210000004970 cd4 cell Anatomy 0.000 claims 5
• 230000006037 cell lysis Effects 0.000 claims 5
• 238000002659 cell therapy Methods 0.000 claims 5
• 239000003795 chemical substances by application Substances 0.000 claims 5
• 230000001186 cumulative effect Effects 0.000 claims 5
• 230000002708 enhancing effect Effects 0.000 claims 5
• 230000017188 evasion or tolerance of host immune response Effects 0.000 claims 5
• 230000003394 haemopoietic effect Effects 0.000 claims 5
• 230000006058 immune tolerance Effects 0.000 claims 5
• 230000003308 immunostimulating effect Effects 0.000 claims 5
• 239000003112 inhibitor Substances 0.000 claims 5
• 230000005764 inhibitory process Effects 0.000 claims 5
• 210000000440 neutrophil Anatomy 0.000 claims 5
• 229920000642 polymer Polymers 0.000 claims 5
• 239000003642 reactive oxygen metabolite Substances 0.000 claims 5
• 230000009467 reduction Effects 0.000 claims 5
• 238000002560 therapeutic procedure Methods 0.000 claims 5
• 230000004614 tumor growth Effects 0.000 claims 5
• 102100023990 60S ribosomal protein L17 Human genes 0.000 claims 4
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 4
• 208000023275 Autoimmune disease Diseases 0.000 claims 4
• 108091008875 B cell receptors Proteins 0.000 claims 4
• 102000002086 C-type lectin-like Human genes 0.000 claims 4
• 108050009406 C-type lectin-like Proteins 0.000 claims 4
• 229940045513 CTLA4 antagonist Drugs 0.000 claims 4
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 4
• ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims 4
• 101100347633 Drosophila melanogaster Mhc gene Proteins 0.000 claims 4
• 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 claims 4
• 102100028970 HLA class I histocompatibility antigen, alpha chain E Human genes 0.000 claims 4
• 102000008949 Histocompatibility Antigens Class I Human genes 0.000 claims 4
• 101000986085 Homo sapiens HLA class I histocompatibility antigen, alpha chain E Proteins 0.000 claims 4
• 101000971513 Homo sapiens Natural killer cells antigen CD94 Proteins 0.000 claims 4
• 101000586618 Homo sapiens Poliovirus receptor Proteins 0.000 claims 4
• 229940076838 Immune checkpoint inhibitor Drugs 0.000 claims 4
• 108010038453 Interleukin-2 Receptors Proteins 0.000 claims 4
• 102000010789 Interleukin-2 Receptors Human genes 0.000 claims 4
• 108091054438 MHC class II family Proteins 0.000 claims 4
• 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 claims 4
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 claims 4
• 241000124008 Mammalia Species 0.000 claims 4
• 108010004222 Natural Cytotoxicity Triggering Receptor 3 Proteins 0.000 claims 4
• 102100021462 Natural killer cells antigen CD94 Human genes 0.000 claims 4
• 102000002356 Nectin Human genes 0.000 claims 4
• 108060005251 Nectin Proteins 0.000 claims 4
• 108050003738 Neural cell adhesion molecule 1 Proteins 0.000 claims 4
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims 4
• 101710089372 Programmed cell death protein 1 Proteins 0.000 claims 4
• 230000006044 T cell activation Effects 0.000 claims 4
• 238000009825 accumulation Methods 0.000 claims 4
• 229910052791 calcium Inorganic materials 0.000 claims 4
• 239000011575 calcium Substances 0.000 claims 4
• 238000002512 chemotherapy Methods 0.000 claims 4
• 230000004154 complement system Effects 0.000 claims 4
• 239000000470 constituent Substances 0.000 claims 4
• 230000034994 death Effects 0.000 claims 4
• 230000003828 downregulation Effects 0.000 claims 4
• 239000012997 ficoll-paque Substances 0.000 claims 4
• 210000004602 germ cell Anatomy 0.000 claims 4
• 239000008187 granular material Substances 0.000 claims 4
• 230000012010 growth Effects 0.000 claims 4
• 239000012274 immune-checkpoint protein inhibitor Substances 0.000 claims 4
• 238000001727 in vivo Methods 0.000 claims 4
• 210000005007 innate immune system Anatomy 0.000 claims 4
• 238000002955 isolation Methods 0.000 claims 4
• 230000000670 limiting effect Effects 0.000 claims 4
• 210000004185 liver Anatomy 0.000 claims 4
• 238000011068 loading method Methods 0.000 claims 4
• 230000002132 lysosomal effect Effects 0.000 claims 4
• 238000012423 maintenance Methods 0.000 claims 4
• 230000000813 microbial effect Effects 0.000 claims 4
• 230000031942 natural killer cell mediated cytotoxicity Effects 0.000 claims 4
• 210000002501 natural regulatory T cell Anatomy 0.000 claims 4
• 238000012545 processing Methods 0.000 claims 4
• 238000012552 review Methods 0.000 claims 4
• 239000000523 sample Substances 0.000 claims 4
• 230000001629 suppression Effects 0.000 claims 4
• 229940124597 therapeutic agent Drugs 0.000 claims 4
• 230000002992 thymic effect Effects 0.000 claims 4
• 230000003612 virological effect Effects 0.000 claims 4
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 3
• HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 claims 3
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 3
• 108090000342 C-Type Lectins Proteins 0.000 claims 3
• 102000003930 C-Type Lectins Human genes 0.000 claims 3
• 102100040840 C-type lectin domain family 7 member A Human genes 0.000 claims 3
• 210000004366 CD4-positive T-lymphocyte Anatomy 0.000 claims 3
• 102100036008 CD48 antigen Human genes 0.000 claims 3
• 108090000835 CX3C Chemokine Receptor 1 Proteins 0.000 claims 3
• 102100039196 CX3C chemokine receptor 1 Human genes 0.000 claims 3
• 108010076667 Caspases Proteins 0.000 claims 3
• 102000011727 Caspases Human genes 0.000 claims 3
• 206010057248 Cell death Diseases 0.000 claims 3
• 108010071942 Colony-Stimulating Factors Proteins 0.000 claims 3
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims 3
• 108010049207 Death Domain Receptors Proteins 0.000 claims 3
• 102000009058 Death Domain Receptors Human genes 0.000 claims 3
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims 3
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims 3
• 108010077716 Fas-Associated Death Domain Protein Proteins 0.000 claims 3
• 102000010579 Fas-Associated Death Domain Protein Human genes 0.000 claims 3
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 3
• 101710197836 HLA class I histocompatibility antigen, alpha chain G Proteins 0.000 claims 3
• 101710154606 Hemagglutinin Proteins 0.000 claims 3
• 102000007346 Hepatitis A Virus Cellular Receptor 2 Human genes 0.000 claims 3
• 108010007707 Hepatitis A Virus Cellular Receptor 2 Proteins 0.000 claims 3
• 101100005713 Homo sapiens CD4 gene Proteins 0.000 claims 3
• 101000716130 Homo sapiens CD48 antigen Proteins 0.000 claims 3
• 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims 3
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 3
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 3
• 102000037984 Inhibitory immune checkpoint proteins Human genes 0.000 claims 3
• 108091008026 Inhibitory immune checkpoint proteins Proteins 0.000 claims 3
• 102000003810 Interleukin-18 Human genes 0.000 claims 3
• 108090000171 Interleukin-18 Proteins 0.000 claims 3
• 108090001005 Interleukin-6 Proteins 0.000 claims 3
• 102000004889 Interleukin-6 Human genes 0.000 claims 3
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 3
• 102100025584 Leukocyte immunoglobulin-like receptor subfamily B member 1 Human genes 0.000 claims 3
• 102000004083 Lymphotoxin-alpha Human genes 0.000 claims 3
• 108090000542 Lymphotoxin-alpha Proteins 0.000 claims 3
• 102100030301 MHC class I polypeptide-related sequence A Human genes 0.000 claims 3
• 102000043131 MHC class II family Human genes 0.000 claims 3
• 102100025354 Macrophage mannose receptor 1 Human genes 0.000 claims 3
• 102000018697 Membrane Proteins Human genes 0.000 claims 3
• 108010052285 Membrane Proteins Proteins 0.000 claims 3
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims 3
• 102100022682 NKG2-A/NKG2-B type II integral membrane protein Human genes 0.000 claims 3
• 108010004217 Natural Cytotoxicity Triggering Receptor 1 Proteins 0.000 claims 3
• 102100029438 Nitric oxide synthase, inducible Human genes 0.000 claims 3
• 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 3
• 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 3
• 108091000080 Phosphotransferase Proteins 0.000 claims 3
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 3
• 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 claims 3
• 101710176177 Protein A56 Proteins 0.000 claims 3
• 230000006052 T cell proliferation Effects 0.000 claims 3
• 102000040945 Transcription factor Human genes 0.000 claims 3
• 108091023040 Transcription factor Proteins 0.000 claims 3
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 3
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 3
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 3
• 150000007513 acids Chemical class 0.000 claims 3
• 102000035181 adaptor proteins Human genes 0.000 claims 3
• 108091005764 adaptor proteins Proteins 0.000 claims 3
• 239000002671 adjuvant Substances 0.000 claims 3
• 230000002411 adverse Effects 0.000 claims 3
• 210000000628 antibody-producing cell Anatomy 0.000 claims 3
• 230000005975 antitumor immune response Effects 0.000 claims 3
• 230000005779 cell damage Effects 0.000 claims 3
• 230000007910 cell fusion Effects 0.000 claims 3
• 230000010261 cell growth Effects 0.000 claims 3
• 239000002771 cell marker Substances 0.000 claims 3
• 230000004637 cellular stress Effects 0.000 claims 3
• 210000003850 cellular structure Anatomy 0.000 claims 3
• 238000012512 characterization method Methods 0.000 claims 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
• 230000000875 corresponding effect Effects 0.000 claims 3
• 230000016396 cytokine production Effects 0.000 claims 3
• 230000006378 damage Effects 0.000 claims 3
• 230000007423 decrease Effects 0.000 claims 3
• 230000003247 decreasing effect Effects 0.000 claims 3
• 230000002950 deficient Effects 0.000 claims 3
• 210000003162 effector t lymphocyte Anatomy 0.000 claims 3
• 238000005516 engineering process Methods 0.000 claims 3
• 210000002744 extracellular matrix Anatomy 0.000 claims 3
• 239000012634 fragment Substances 0.000 claims 3
• 238000007710 freezing Methods 0.000 claims 3
• 230000008014 freezing Effects 0.000 claims 3
• 210000001035 gastrointestinal tract Anatomy 0.000 claims 3
• 239000003102 growth factor Substances 0.000 claims 3
• 239000000185 hemagglutinin Substances 0.000 claims 3
• 210000003630 histaminocyte Anatomy 0.000 claims 3
• 230000037451 immune surveillance Effects 0.000 claims 3
• 230000006054 immunological memory Effects 0.000 claims 3
• 102000006639 indoleamine 2,3-dioxygenase Human genes 0.000 claims 3
• 108020004201 indoleamine 2,3-dioxygenase Proteins 0.000 claims 3
• 230000002458 infectious effect Effects 0.000 claims 3
• 230000008595 infiltration Effects 0.000 claims 3
• 238000001764 infiltration Methods 0.000 claims 3
• 239000007788 liquid Substances 0.000 claims 3
• 210000005210 lymphoid organ Anatomy 0.000 claims 3
• 230000002934 lysing effect Effects 0.000 claims 3
• 230000003211 malignant effect Effects 0.000 claims 3
• 201000001441 melanoma Diseases 0.000 claims 3
• 230000015654 memory Effects 0.000 claims 3
• 230000003641 microbiacidal effect Effects 0.000 claims 3
• 230000005012 migration Effects 0.000 claims 3
• 238000013508 migration Methods 0.000 claims 3
• 210000003643 myeloid progenitor cell Anatomy 0.000 claims 3
• 231100000252 nontoxic Toxicity 0.000 claims 3
• 230000003000 nontoxic effect Effects 0.000 claims 3
• 239000002245 particle Substances 0.000 claims 3
• 230000001575 pathological effect Effects 0.000 claims 3
• CMFNMSMUKZHDEY-UHFFFAOYSA-M peroxynitrite Chemical compound [O-]ON=O CMFNMSMUKZHDEY-UHFFFAOYSA-M 0.000 claims 3
• 230000026731 phosphorylation Effects 0.000 claims 3
• 238000006366 phosphorylation reaction Methods 0.000 claims 3
• 102000020233 phosphotransferase Human genes 0.000 claims 3
• 210000002381 plasma Anatomy 0.000 claims 3
• 230000010287 polarization Effects 0.000 claims 3
• 229910052700 potassium Inorganic materials 0.000 claims 3
• 239000011591 potassium Substances 0.000 claims 3
• 230000002265 prevention Effects 0.000 claims 3
• 230000001737 promoting effect Effects 0.000 claims 3
• XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 claims 3
• 108020001580 protein domains Proteins 0.000 claims 3
• 238000000746 purification Methods 0.000 claims 3
• 230000007115 recruitment Effects 0.000 claims 3
• 230000003248 secreting effect Effects 0.000 claims 3
• 229910052708 sodium Inorganic materials 0.000 claims 3
• 239000011734 sodium Substances 0.000 claims 3
• 230000004936 stimulating effect Effects 0.000 claims 3
• 210000002536 stromal cell Anatomy 0.000 claims 3
• 230000002195 synergetic effect Effects 0.000 claims 3
• 230000008685 targeting Effects 0.000 claims 3
• 238000010257 thawing Methods 0.000 claims 3
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 3
• 238000002054 transplantation Methods 0.000 claims 3
• 230000002476 tumorcidal effect Effects 0.000 claims 3
• BSDCIRGNJKZPFV-GWOFURMSSA-N (2r,3s,4r,5r)-2-(hydroxymethyl)-5-(2,5,6-trichlorobenzimidazol-1-yl)oxolane-3,4-diol Chemical group O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=CC(Cl)=C(Cl)C=C2N=C1Cl BSDCIRGNJKZPFV-GWOFURMSSA-N 0.000 claims 2
• RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 claims 2
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims 2
• MJKVTPMWOKAVMS-UHFFFAOYSA-N 3-hydroxy-1-benzopyran-2-one Chemical compound C1=CC=C2OC(=O)C(O)=CC2=C1 MJKVTPMWOKAVMS-UHFFFAOYSA-N 0.000 claims 2
• 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims 2
• 102000006306 Antigen Receptors Human genes 0.000 claims 2
• 108010083359 Antigen Receptors Proteins 0.000 claims 2
• 102000004452 Arginase Human genes 0.000 claims 2
• 108700024123 Arginases Proteins 0.000 claims 2
• 239000004475 Arginine Substances 0.000 claims 2
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
• 102100035634 B-cell linker protein Human genes 0.000 claims 2
• BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims 2
• 206010006187 Breast cancer Diseases 0.000 claims 2
• 208000026310 Breast neoplasm Diseases 0.000 claims 2
• 102100037853 C-C chemokine receptor type 4 Human genes 0.000 claims 2
• 101710149863 C-C chemokine receptor type 4 Proteins 0.000 claims 2
• 102100039521 C-type lectin domain family 9 member A Human genes 0.000 claims 2
• 108010021064 CTLA-4 Antigen Proteins 0.000 claims 2
• 102000010919 CXC chemokine receptor 3 Human genes 0.000 claims 2
• 108010061300 CXCR3 Receptors Proteins 0.000 claims 2
• 102000000844 Cell Surface Receptors Human genes 0.000 claims 2
• 108010001857 Cell Surface Receptors Proteins 0.000 claims 2
• 102000007644 Colony-Stimulating Factors Human genes 0.000 claims 2
• 108010034753 Complement Membrane Attack Complex Proteins 0.000 claims 2
• 108010069112 Complement System Proteins Proteins 0.000 claims 2
• 102000000989 Complement System Proteins Human genes 0.000 claims 2
• 102000053602 DNA Human genes 0.000 claims 2
• 102000036292 Death effector domains Human genes 0.000 claims 2
• 108091010866 Death effector domains Proteins 0.000 claims 2
• QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 claims 2
• 102100029111 Fatty-acid amide hydrolase 1 Human genes 0.000 claims 2
• 108010087819 Fc receptors Proteins 0.000 claims 2
• 102000009109 Fc receptors Human genes 0.000 claims 2
• 108010029961 Filgrastim Proteins 0.000 claims 2
• 206010056740 Genital discharge Diseases 0.000 claims 2
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 2
• 102100021186 Granulysin Human genes 0.000 claims 2
• 101710168479 Granulysin Proteins 0.000 claims 2
• 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 claims 2
• 102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 claims 2
• 108010075704 HLA-A Antigens Proteins 0.000 claims 2
• 102000006354 HLA-DR Antigens Human genes 0.000 claims 2
• 108010024164 HLA-G Antigens Proteins 0.000 claims 2
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 2
• 108010088652 Histocompatibility Antigens Class I Proteins 0.000 claims 2
• 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims 2
• 101000888548 Homo sapiens C-type lectin domain family 9 member A Proteins 0.000 claims 2
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 2
• 101000959820 Homo sapiens Interferon alpha-1/13 Proteins 0.000 claims 2
• 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 claims 2
• 101000984199 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily A member 4 Proteins 0.000 claims 2
• 101000984190 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 1 Proteins 0.000 claims 2
• 101000868279 Homo sapiens Leukocyte surface antigen CD47 Proteins 0.000 claims 2
• 101000917826 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-a Proteins 0.000 claims 2
• 101000917824 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-b Proteins 0.000 claims 2
• 101000991060 Homo sapiens MHC class I polypeptide-related sequence A Proteins 0.000 claims 2
• 101000991061 Homo sapiens MHC class I polypeptide-related sequence B Proteins 0.000 claims 2
• 101000576894 Homo sapiens Macrophage mannose receptor 1 Proteins 0.000 claims 2
• 101001109508 Homo sapiens NKG2-A/NKG2-B type II integral membrane protein Proteins 0.000 claims 2
• 101000589307 Homo sapiens Natural cytotoxicity triggering receptor 3 Proteins 0.000 claims 2
• 101000809875 Homo sapiens TYRO protein tyrosine kinase-binding protein Proteins 0.000 claims 2
• 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 claims 2
• 241000701024 Human betaherpesvirus 5 Species 0.000 claims 2
• 206010061218 Inflammation Diseases 0.000 claims 2
• 102100040019 Interferon alpha-1/13 Human genes 0.000 claims 2
• 102000014150 Interferons Human genes 0.000 claims 2
• 108010050904 Interferons Proteins 0.000 claims 2
• 108010017535 Interleukin-15 Receptors Proteins 0.000 claims 2
• 102000004556 Interleukin-15 Receptors Human genes 0.000 claims 2
• 102000013691 Interleukin-17 Human genes 0.000 claims 2
• 108050003558 Interleukin-17 Proteins 0.000 claims 2
• 108010002586 Interleukin-7 Proteins 0.000 claims 2
• 102100021592 Interleukin-7 Human genes 0.000 claims 2
• 102100026236 Interleukin-8 Human genes 0.000 claims 2
• 102000002698 KIR Receptors Human genes 0.000 claims 2
• 108010043610 KIR Receptors Proteins 0.000 claims 2
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 2
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 2
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 2
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 2
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 2
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 2
• 102000004856 Lectins Human genes 0.000 claims 2
• 108090001090 Lectins Proteins 0.000 claims 2
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 2
• 102100025555 Leukocyte immunoglobulin-like receptor subfamily A member 4 Human genes 0.000 claims 2
• 102100032913 Leukocyte surface antigen CD47 Human genes 0.000 claims 2
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims 2
• 102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 claims 2
• 102000008072 Lymphokines Human genes 0.000 claims 2
• 108010074338 Lymphokines Proteins 0.000 claims 2
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 2
• 239000004472 Lysine Substances 0.000 claims 2
• 108010075639 MAP Kinase Kinase Kinase 5 Proteins 0.000 claims 2
• 108700005092 MHC Class II Genes Proteins 0.000 claims 2
• 102100030300 MHC class I polypeptide-related sequence B Human genes 0.000 claims 2
• 102000009571 Macrophage Inflammatory Proteins Human genes 0.000 claims 2
• 108010009474 Macrophage Inflammatory Proteins Proteins 0.000 claims 2
• BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims 2
• 102100038243 Mitogen-activated protein kinase kinase kinase 10 Human genes 0.000 claims 2
• 101710084006 Mitogen-activated protein kinase kinase kinase 10 Proteins 0.000 claims 2
• 102100033127 Mitogen-activated protein kinase kinase kinase 5 Human genes 0.000 claims 2
• 241001529936 Murinae Species 0.000 claims 2
• 101000912601 Mus musculus C-type lectin domain family 2 member I Proteins 0.000 claims 2
• 101100335081 Mus musculus Flt3 gene Proteins 0.000 claims 2
• 101001049180 Mus musculus Killer cell lectin-like receptor subfamily B member 1C Proteins 0.000 claims 2
• 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 claims 2
• NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims 2
• 206010029260 Neuroblastoma Diseases 0.000 claims 2
• 101710089543 Nitric oxide synthase, inducible Proteins 0.000 claims 2
• GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 claims 2
• 108700020796 Oncogene Proteins 0.000 claims 2
• 108700026244 Open Reading Frames Proteins 0.000 claims 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
• 108010004729 Phycoerythrin Proteins 0.000 claims 2
• GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
• NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
• 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 claims 2
• 102100035703 Prostatic acid phosphatase Human genes 0.000 claims 2
• 208000035415 Reinfection Diseases 0.000 claims 2
• 108010011005 STAT6 Transcription Factor Proteins 0.000 claims 2
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 2
• 102100023980 Signal transducer and activator of transcription 6 Human genes 0.000 claims 2
• 108010008038 Synthetic Vaccines Proteins 0.000 claims 2
• 210000000662 T-lymphocyte subset Anatomy 0.000 claims 2
• 102100038717 TYRO protein tyrosine kinase-binding protein Human genes 0.000 claims 2
• NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 claims 2
• 102100028082 Tapasin Human genes 0.000 claims 2
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 2
• 239000004473 Threonine Substances 0.000 claims 2
• 102100024324 Toll-like receptor 3 Human genes 0.000 claims 2
• 102100033117 Toll-like receptor 9 Human genes 0.000 claims 2
• 108010009583 Transforming Growth Factors Proteins 0.000 claims 2
• 102000009618 Transforming Growth Factors Human genes 0.000 claims 2
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 2
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims 2
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 2
• 239000004480 active ingredient Substances 0.000 claims 2
• 239000000556 agonist Substances 0.000 claims 2
• 235000004279 alanine Nutrition 0.000 claims 2
• 229910052783 alkali metal Inorganic materials 0.000 claims 2
• 150000001340 alkali metals Chemical class 0.000 claims 2
• 229910052784 alkaline earth metal Inorganic materials 0.000 claims 2
• 150000001342 alkaline earth metals Chemical class 0.000 claims 2
• 208000026935 allergic disease Diseases 0.000 claims 2
• 230000004075 alteration Effects 0.000 claims 2
• 150000001412 amines Chemical class 0.000 claims 2
• 229910021529 ammonia Inorganic materials 0.000 claims 2
• 238000004458 analytical method Methods 0.000 claims 2
• 239000005557 antagonist Substances 0.000 claims 2
• 230000005809 anti-tumor immunity Effects 0.000 claims 2
• 230000005875 antibody response Effects 0.000 claims 2
• 238000013459 approach Methods 0.000 claims 2
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 2
• 235000009582 asparagine Nutrition 0.000 claims 2
• 229960001230 asparagine Drugs 0.000 claims 2
• 235000003704 aspartic acid Nutrition 0.000 claims 2
• 230000001363 autoimmune Effects 0.000 claims 2
• 230000005784 autoimmunity Effects 0.000 claims 2
• 210000003651 basophil Anatomy 0.000 claims 2
• 230000009286 beneficial effect Effects 0.000 claims 2
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 2
• 230000002457 bidirectional effect Effects 0.000 claims 2
• 239000013060 biological fluid Substances 0.000 claims 2
• 230000000903 blocking effect Effects 0.000 claims 2
• 210000001124 body fluid Anatomy 0.000 claims 2
• 239000010839 body fluid Substances 0.000 claims 2
• 210000004556 brain Anatomy 0.000 claims 2
• 210000000481 breast Anatomy 0.000 claims 2
• 150000001649 bromium compounds Chemical class 0.000 claims 2
• 230000005907 cancer growth Effects 0.000 claims 2
• 150000001720 carbohydrates Chemical class 0.000 claims 2
• 230000015556 catabolic process Effects 0.000 claims 2
• 230000003197 catalytic effect Effects 0.000 claims 2
• 150000001768 cations Chemical class 0.000 claims 2
• 238000004113 cell culture Methods 0.000 claims 2
• 230000011712 cell development Effects 0.000 claims 2
• 230000004663 cell proliferation Effects 0.000 claims 2
• 239000002458 cell surface marker Substances 0.000 claims 2
• 239000006285 cell suspension Substances 0.000 claims 2
• 230000007969 cellular immunity Effects 0.000 claims 2
• 230000006020 chronic inflammation Effects 0.000 claims 2
• 208000037976 chronic inflammation Diseases 0.000 claims 2
• 210000001228 classical NK T cell Anatomy 0.000 claims 2
• 229940047120 colony stimulating factors Drugs 0.000 claims 2
• 239000002299 complementary DNA Substances 0.000 claims 2
• 230000001276 controlling effect Effects 0.000 claims 2
• 108091008034 costimulatory receptors Proteins 0.000 claims 2
• 235000018417 cysteine Nutrition 0.000 claims 2
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims 2
• 230000010013 cytotoxic mechanism Effects 0.000 claims 2
• 108010025838 dectin 1 Proteins 0.000 claims 2
• 238000006731 degradation reaction Methods 0.000 claims 2
• BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 claims 2
• 238000009826 distribution Methods 0.000 claims 2
• 229940126534 drug product Drugs 0.000 claims 2
• 230000012202 endocytosis Effects 0.000 claims 2
• 210000003979 eosinophil Anatomy 0.000 claims 2
• 210000002919 epithelial cell Anatomy 0.000 claims 2
• 210000003743 erythrocyte Anatomy 0.000 claims 2
• 210000001808 exosome Anatomy 0.000 claims 2
• 108010046094 fatty-acid amide hydrolase Proteins 0.000 claims 2
• 239000007850 fluorescent dye Substances 0.000 claims 2
• 108010021843 fluorescent protein 583 Proteins 0.000 claims 2
• 230000005714 functional activity Effects 0.000 claims 2
• 102000037865 fusion proteins Human genes 0.000 claims 2
• 108020001507 fusion proteins Proteins 0.000 claims 2
• 235000013922 glutamic acid Nutrition 0.000 claims 2
• 239000004220 glutamic acid Substances 0.000 claims 2
• 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 claims 2
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 2
• 210000003714 granulocyte Anatomy 0.000 claims 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims 2
• 239000000833 heterodimer Substances 0.000 claims 2
• 230000003284 homeostatic effect Effects 0.000 claims 2
• 229940121569 ieramilimab Drugs 0.000 claims 2
• 230000008073 immune recognition Effects 0.000 claims 2
• 230000006028 immune-suppresssive effect Effects 0.000 claims 2
• 230000016784 immunoglobulin production Effects 0.000 claims 2
• 230000007365 immunoregulation Effects 0.000 claims 2
• 238000011065 in-situ storage Methods 0.000 claims 2
• 230000002779 inactivation Effects 0.000 claims 2
• 238000011534 incubation Methods 0.000 claims 2
• 210000002602 induced regulatory T cell Anatomy 0.000 claims 2
• 230000004054 inflammatory process Effects 0.000 claims 2
• 230000028709 inflammatory response Effects 0.000 claims 2
• 238000001802 infusion Methods 0.000 claims 2
• 238000011081 inoculation Methods 0.000 claims 2
• 230000010354 integration Effects 0.000 claims 2
• 102000006495 integrins Human genes 0.000 claims 2
• 108010044426 integrins Proteins 0.000 claims 2
• 229940047122 interleukins Drugs 0.000 claims 2
• 230000016507 interphase Effects 0.000 claims 2
• 150000004694 iodide salts Chemical class 0.000 claims 2
• 230000007794 irritation Effects 0.000 claims 2
• 229960000310 isoleucine Drugs 0.000 claims 2
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 2
• 210000003734 kidney Anatomy 0.000 claims 2
• 239000002523 lectin Substances 0.000 claims 2
• 229910052744 lithium Inorganic materials 0.000 claims 2
• 210000004072 lung Anatomy 0.000 claims 2
• 210000002751 lymph Anatomy 0.000 claims 2
• 230000002101 lytic effect Effects 0.000 claims 2
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 2
• 239000011159 matrix material Substances 0.000 claims 2
• 210000003519 mature b lymphocyte Anatomy 0.000 claims 2
• 108020004999 messenger RNA Proteins 0.000 claims 2
• 229910052751 metal Inorganic materials 0.000 claims 2
• 239000002184 metal Substances 0.000 claims 2
• 208000010658 metastatic prostate carcinoma Diseases 0.000 claims 2
• VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims 2
• 229930182817 methionine Natural products 0.000 claims 2
• HQCYVSPJIOJEGA-UHFFFAOYSA-N methoxycoumarin Chemical compound C1=CC=C2OC(=O)C(OC)=CC2=C1 HQCYVSPJIOJEGA-UHFFFAOYSA-N 0.000 claims 2
• 238000000386 microscopy Methods 0.000 claims 2
• 230000004048 modification Effects 0.000 claims 2
• 238000012986 modification Methods 0.000 claims 2
• 238000009126 molecular therapy Methods 0.000 claims 2
• 239000000178 monomer Substances 0.000 claims 2
• 230000035772 mutation Effects 0.000 claims 2
• 230000001338 necrotic effect Effects 0.000 claims 2
• 210000005170 neoplastic cell Anatomy 0.000 claims 2
• 230000000802 nitrating effect Effects 0.000 claims 2
• 210000000056 organ Anatomy 0.000 claims 2
• 150000007524 organic acids Chemical class 0.000 claims 2
• 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 claims 2
• 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 claims 2
• 230000000242 pagocytic effect Effects 0.000 claims 2
• 210000002741 palatine tonsil Anatomy 0.000 claims 2
• 230000007170 pathology Effects 0.000 claims 2
• 239000000825 pharmaceutical preparation Substances 0.000 claims 2
• 230000000144 pharmacologic effect Effects 0.000 claims 2
• 238000002135 phase contrast microscopy Methods 0.000 claims 2
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 2
• 239000000902 placebo Substances 0.000 claims 2
• 229940068196 placebo Drugs 0.000 claims 2
• 230000036470 plasma concentration Effects 0.000 claims 2
• 238000010837 poor prognosis Methods 0.000 claims 2
• 239000011148 porous material Substances 0.000 claims 2
• 230000004481 post-translational protein modification Effects 0.000 claims 2
• 230000037452 priming Effects 0.000 claims 2
• 230000000069 prophylactic effect Effects 0.000 claims 2
• 108010043671 prostatic acid phosphatase Proteins 0.000 claims 2
• 230000017854 proteolysis Effects 0.000 claims 2
• 150000003212 purines Chemical class 0.000 claims 2
• 150000003254 radicals Chemical class 0.000 claims 2
• 230000009257 reactivity Effects 0.000 claims 2
• 230000003134 recirculating effect Effects 0.000 claims 2
• 230000006798 recombination Effects 0.000 claims 2
• 238000005215 recombination Methods 0.000 claims 2
• 230000009711 regulatory function Effects 0.000 claims 2
• 229940121484 relatlimab Drugs 0.000 claims 2
• 238000007634 remodeling Methods 0.000 claims 2
• 230000003252 repetitive effect Effects 0.000 claims 2
• 230000004043 responsiveness Effects 0.000 claims 2
• 230000035945 sensitivity Effects 0.000 claims 2
• 229960000714 sipuleucel-t Drugs 0.000 claims 2
• 210000003491 skin Anatomy 0.000 claims 2
• 238000001228 spectrum Methods 0.000 claims 2
• 238000010186 staining Methods 0.000 claims 2
• 238000010561 standard procedure Methods 0.000 claims 2
• KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 2
• 210000000225 synapse Anatomy 0.000 claims 2
• 230000002123 temporal effect Effects 0.000 claims 2
• ACOJCCLIDPZYJC-UHFFFAOYSA-M thiazole orange Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC=C2C(C=C3N(C4=CC=CC=C4S3)C)=CC=[N+](C)C2=C1 ACOJCCLIDPZYJC-UHFFFAOYSA-M 0.000 claims 2
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims 2
• 230000025366 tissue development Effects 0.000 claims 2
• 230000030968 tissue homeostasis Effects 0.000 claims 2
• 231100000331 toxic Toxicity 0.000 claims 2
• 230000002588 toxic effect Effects 0.000 claims 2
• 230000035897 transcription Effects 0.000 claims 2
• 238000013518 transcription Methods 0.000 claims 2
• 230000002103 transcriptional effect Effects 0.000 claims 2
• 102000035160 transmembrane proteins Human genes 0.000 claims 2
• 108091005703 transmembrane proteins Proteins 0.000 claims 2
• GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims 2
• 238000002255 vaccination Methods 0.000 claims 2
• 239000004474 valine Substances 0.000 claims 2
• LSPHULWDVZXLIL-UHFFFAOYSA-N (+/-)-Camphoric acid Chemical compound CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 claims 1
• CZWUESRDTYLNDE-UHFFFAOYSA-N (2z)-2-[(2e,4e,6e)-7-[1-(5-carboxypentyl)-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]hepta-2,4,6-trienylidene]-1-ethyl-3,3-dimethylindole-5-sulfonate Chemical compound CC1(C)C2=CC(S([O-])(=O)=O)=CC=C2N(CC)\C1=C/C=C/C=C/C=C/C1=[N+](CCCCCC(O)=O)C2=CC=C(S(O)(=O)=O)C=C2C1(C)C CZWUESRDTYLNDE-UHFFFAOYSA-N 0.000 claims 1
• QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical compound [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 claims 1
• BXSULSOCJNTUJS-YTBMLWRQSA-N 1-(3-O-sulfo-beta-D-galactosyl)sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(O)(=O)=O)[C@H]1O BXSULSOCJNTUJS-YTBMLWRQSA-N 0.000 claims 1
• VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical class CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 claims 1
• VUQPJRPDRDVQMN-UHFFFAOYSA-N 1-chlorooctadecane Chemical class CCCCCCCCCCCCCCCCCCCl VUQPJRPDRDVQMN-UHFFFAOYSA-N 0.000 claims 1
• PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 claims 1
• ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 claims 1
• XDFNWJDGWJVGGN-UHFFFAOYSA-N 2-(2,7-dichloro-3,6-dihydroxy-9h-xanthen-9-yl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC(Cl)=C(O)C=C2OC2=CC(O)=C(Cl)C=C21 XDFNWJDGWJVGGN-UHFFFAOYSA-N 0.000 claims 1
• IOOMXAQUNPWDLL-UHFFFAOYSA-N 2-[6-(diethylamino)-3-(diethyliminiumyl)-3h-xanthen-9-yl]-5-sulfobenzene-1-sulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(O)(=O)=O)C=C1S([O-])(=O)=O IOOMXAQUNPWDLL-UHFFFAOYSA-N 0.000 claims 1
• ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 claims 1
• RSGFPIWWSCWCFJ-VAXZQHAWSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O RSGFPIWWSCWCFJ-VAXZQHAWSA-N 0.000 claims 1
• 229940080296 2-naphthalenesulfonate Drugs 0.000 claims 1
• WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical class BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 claims 1
• QWZHDKGQKYEBKK-UHFFFAOYSA-N 3-aminochromen-2-one Chemical compound C1=CC=C2OC(=O)C(N)=CC2=C1 QWZHDKGQKYEBKK-UHFFFAOYSA-N 0.000 claims 1
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims 1
• XMIIGOLPHOKFCH-UHFFFAOYSA-M 3-phenylpropionate Chemical compound [O-]C(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-M 0.000 claims 1
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 claims 1
• LIZDKDDCWIEQIN-UHFFFAOYSA-N 6-[2-[5-(3-ethyl-1,1-dimethyl-6,8-disulfobenzo[e]indol-2-ylidene)penta-1,3-dienyl]-1,1-dimethyl-6,8-disulfobenzo[e]indol-3-ium-3-yl]hexanoate Chemical compound C1=CC2=C(S(O)(=O)=O)C=C(S(O)(=O)=O)C=C2C(C2(C)C)=C1N(CC)\C2=C\C=C\C=C\C1=[N+](CCCCCC([O-])=O)C2=CC=C(C(=CC(=C3)S(O)(=O)=O)S(O)(=O)=O)C3=C2C1(C)C LIZDKDDCWIEQIN-UHFFFAOYSA-N 0.000 claims 1
• FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
• YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 claims 1
• 108700012813 7-aminoactinomycin D Proteins 0.000 claims 1
• 230000005730 ADP ribosylation Effects 0.000 claims 1
• 102100032814 ATP-dependent zinc metalloprotease YME1L1 Human genes 0.000 claims 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
• 229930024421 Adenine Natural products 0.000 claims 1
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims 1
• 102100035248 Alpha-(1,3)-fucosyltransferase 4 Human genes 0.000 claims 1
• 102100022749 Aminopeptidase N Human genes 0.000 claims 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
• 206010002198 Anaphylactic reaction Diseases 0.000 claims 1
• 102100030346 Antigen peptide transporter 1 Human genes 0.000 claims 1
• 102100030343 Antigen peptide transporter 2 Human genes 0.000 claims 1
• 102100029470 Apolipoprotein E Human genes 0.000 claims 1
• 101710095339 Apolipoprotein E Proteins 0.000 claims 1
• 102000019260 B-Cell Antigen Receptors Human genes 0.000 claims 1
• 108010012919 B-Cell Antigen Receptors Proteins 0.000 claims 1
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 1
• 108010074708 B7-H1 Antigen Proteins 0.000 claims 1
• 102100026189 Beta-galactosidase Human genes 0.000 claims 1
• 206010005003 Bladder cancer Diseases 0.000 claims 1
• 208000003174 Brain Neoplasms Diseases 0.000 claims 1
• FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims 1
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims 1
• 102100031151 C-C chemokine receptor type 2 Human genes 0.000 claims 1
• 102100028668 C-type lectin domain family 4 member C Human genes 0.000 claims 1
• 238000011357 CAR T-cell therapy Methods 0.000 claims 1
• 108010017088 CCR5 Receptors Proteins 0.000 claims 1
• 102000004274 CCR5 Receptors Human genes 0.000 claims 1
• 102100021992 CD209 antigen Human genes 0.000 claims 1
• 102100027207 CD27 antigen Human genes 0.000 claims 1
• 102100022002 CD59 glycoprotein Human genes 0.000 claims 1
• 239000012275 CTLA-4 inhibitor Substances 0.000 claims 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
• 108010078791 Carrier Proteins Proteins 0.000 claims 1
• 206010008342 Cervix carcinoma Diseases 0.000 claims 1
• 102000009410 Chemokine receptor Human genes 0.000 claims 1
• 108050000299 Chemokine receptor Proteins 0.000 claims 1
• 108091007741 Chimeric antigen receptor T cells Proteins 0.000 claims 1
• 108010077544 Chromatin Proteins 0.000 claims 1
• RURLVUZRUFHCJO-UHFFFAOYSA-N Chromomycin A3 Natural products COC(C1Cc2cc3cc(OC4CC(OC(=O)C)C(OC5CC(O)C(OC)C(C)O5)C(C)O4)c(C)c(O)c3c(O)c2C(=O)C1OC6CC(OC7CC(C)(O)C(OC(=O)C)C(C)O7)C(O)C(C)O6)C(=O)C(O)C(C)O RURLVUZRUFHCJO-UHFFFAOYSA-N 0.000 claims 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
• 102000016574 Complement C3-C5 Convertases Human genes 0.000 claims 1
• 108010067641 Complement C3-C5 Convertases Proteins 0.000 claims 1
• 102100030886 Complement receptor type 1 Human genes 0.000 claims 1
• 102000000529 Costimulatory and Inhibitory T-Cell Receptors Human genes 0.000 claims 1
• 108010041504 Costimulatory and Inhibitory T-Cell Receptors Proteins 0.000 claims 1
• 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 claims 1
• 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 claims 1
• 102100023033 Cyclic AMP-dependent transcription factor ATF-2 Human genes 0.000 claims 1
• 108050006400 Cyclin Proteins 0.000 claims 1
• 150000008574 D-amino acids Chemical class 0.000 claims 1
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims 1
• 108010037897 DC-specific ICAM-3 grabbing nonintegrin Proteins 0.000 claims 1
• 101100239628 Danio rerio myca gene Proteins 0.000 claims 1
• 102000010170 Death domains Human genes 0.000 claims 1
• 108050001718 Death domains Proteins 0.000 claims 1
• 206010011968 Decreased immune responsiveness Diseases 0.000 claims 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 1
• 102100023275 Dual specificity mitogen-activated protein kinase kinase 3 Human genes 0.000 claims 1
• 102100023401 Dual specificity mitogen-activated protein kinase kinase 6 Human genes 0.000 claims 1
• 108091005941 EBFP Proteins 0.000 claims 1
• 108091005942 ECFP Proteins 0.000 claims 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 1
• 102000001301 EGF receptor Human genes 0.000 claims 1
• 108060006698 EGF receptor Proteins 0.000 claims 1
• 101150029707 ERBB2 gene Proteins 0.000 claims 1
• 238000011510 Elispot assay Methods 0.000 claims 1
• 241000196324 Embryophyta Species 0.000 claims 1
• 241000991587 Enterovirus C Species 0.000 claims 1
• BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 claims 1
• PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims 1
• 102000015212 Fas Ligand Protein Human genes 0.000 claims 1
• 108010039471 Fas Ligand Protein Proteins 0.000 claims 1
• 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims 1
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims 1
• OZLGRUXZXMRXGP-UHFFFAOYSA-N Fluo-3 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=C(C=2)C2=C3C=C(Cl)C(=O)C=C3OC3=CC(O)=C(Cl)C=C32)N(CC(O)=O)CC(O)=O)=C1 OZLGRUXZXMRXGP-UHFFFAOYSA-N 0.000 claims 1
• 108090000852 Forkhead Transcription Factors Proteins 0.000 claims 1
• 102100027581 Forkhead box protein P3 Human genes 0.000 claims 1
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 1
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 claims 1
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 claims 1
• 102220566469 GDNF family receptor alpha-1_S65T_mutation Human genes 0.000 claims 1
• 102220566451 GDNF family receptor alpha-1_Y66H_mutation Human genes 0.000 claims 1
• 102100021260 Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 Human genes 0.000 claims 1
• 101001066288 Gallus gallus GATA-binding factor 3 Proteins 0.000 claims 1
• 208000032612 Glial tumor Diseases 0.000 claims 1
• 206010018338 Glioma Diseases 0.000 claims 1
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 1
• 102000003886 Glycoproteins Human genes 0.000 claims 1
• 108090000288 Glycoproteins Proteins 0.000 claims 1
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 1
• 102100028971 HLA class I histocompatibility antigen, C alpha chain Human genes 0.000 claims 1
• 102100031547 HLA class II histocompatibility antigen, DO alpha chain Human genes 0.000 claims 1
• 108010035452 HLA-A1 Antigen Proteins 0.000 claims 1
• 108010086377 HLA-A3 Antigen Proteins 0.000 claims 1
• 108010058607 HLA-B Antigens Proteins 0.000 claims 1
• 108010052199 HLA-C Antigens Proteins 0.000 claims 1
• 102000015789 HLA-DP Antigens Human genes 0.000 claims 1
• 108010010378 HLA-DP Antigens Proteins 0.000 claims 1
• 108010062347 HLA-DQ Antigens Proteins 0.000 claims 1
• 108010058597 HLA-DR Antigens Proteins 0.000 claims 1
• 208000002250 Hematologic Neoplasms Diseases 0.000 claims 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 1
• SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims 1
• 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 claims 1
• 102000018713 Histocompatibility Antigens Class II Human genes 0.000 claims 1
• 101001022185 Homo sapiens Alpha-(1,3)-fucosyltransferase 4 Proteins 0.000 claims 1
• 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 claims 1
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 1
• 101000766907 Homo sapiens C-type lectin domain family 4 member C Proteins 0.000 claims 1
• 101000749325 Homo sapiens C-type lectin domain family 7 member A Proteins 0.000 claims 1
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims 1
• 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 claims 1
• 101000727061 Homo sapiens Complement receptor type 1 Proteins 0.000 claims 1
• 101000974934 Homo sapiens Cyclic AMP-dependent transcription factor ATF-2 Proteins 0.000 claims 1
• 101000725401 Homo sapiens Cytochrome c oxidase subunit 2 Proteins 0.000 claims 1
• 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims 1
• 101001115394 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 3 Proteins 0.000 claims 1
• 101000624426 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 6 Proteins 0.000 claims 1
• 101000861452 Homo sapiens Forkhead box protein P3 Proteins 0.000 claims 1
• 101000894906 Homo sapiens Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 Proteins 0.000 claims 1
• 101000997829 Homo sapiens Glial cell line-derived neurotrophic factor Proteins 0.000 claims 1
• 101000986084 Homo sapiens HLA class I histocompatibility antigen, C alpha chain Proteins 0.000 claims 1
• 101000866278 Homo sapiens HLA class II histocompatibility antigen, DO alpha chain Proteins 0.000 claims 1
• 101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 claims 1
• 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 claims 1
• 101001054334 Homo sapiens Interferon beta Proteins 0.000 claims 1
• 101001011441 Homo sapiens Interferon regulatory factor 4 Proteins 0.000 claims 1
• 101001011442 Homo sapiens Interferon regulatory factor 5 Proteins 0.000 claims 1
• 101001032345 Homo sapiens Interferon regulatory factor 8 Proteins 0.000 claims 1
• 101001033312 Homo sapiens Interleukin-4 receptor subunit alpha Proteins 0.000 claims 1
• 101000945371 Homo sapiens Killer cell immunoglobulin-like receptor 2DL2 Proteins 0.000 claims 1
• 101000945333 Homo sapiens Killer cell immunoglobulin-like receptor 2DL3 Proteins 0.000 claims 1
• 101000945339 Homo sapiens Killer cell immunoglobulin-like receptor 2DS2 Proteins 0.000 claims 1
• 101000945351 Homo sapiens Killer cell immunoglobulin-like receptor 3DL1 Proteins 0.000 claims 1
• 101000945490 Homo sapiens Killer cell immunoglobulin-like receptor 3DL2 Proteins 0.000 claims 1
• 101000945492 Homo sapiens Killer cell immunoglobulin-like receptor 3DS1 Proteins 0.000 claims 1
• 101000697493 Homo sapiens Large proline-rich protein BAG6 Proteins 0.000 claims 1
• 101000934372 Homo sapiens Macrosialin Proteins 0.000 claims 1
• 101000990902 Homo sapiens Matrix metalloproteinase-9 Proteins 0.000 claims 1
• 101001005602 Homo sapiens Mitogen-activated protein kinase kinase kinase 11 Proteins 0.000 claims 1
• 101100460850 Homo sapiens NCR3LG1 gene Proteins 0.000 claims 1
• 101001128158 Homo sapiens Nanos homolog 2 Proteins 0.000 claims 1
• 101000589301 Homo sapiens Natural cytotoxicity triggering receptor 1 Proteins 0.000 claims 1
• 101001124991 Homo sapiens Nitric oxide synthase, inducible Proteins 0.000 claims 1
• 101000605127 Homo sapiens Prostaglandin G/H synthase 2 Proteins 0.000 claims 1
• 101000945096 Homo sapiens Ribosomal protein S6 kinase alpha-5 Proteins 0.000 claims 1
• 101000633786 Homo sapiens SLAM family member 6 Proteins 0.000 claims 1
• 101001092910 Homo sapiens Serum amyloid P-component Proteins 0.000 claims 1
• 101000595548 Homo sapiens TIR domain-containing adapter molecule 1 Proteins 0.000 claims 1
• 101000649068 Homo sapiens Tapasin Proteins 0.000 claims 1
• 101000669402 Homo sapiens Toll-like receptor 7 Proteins 0.000 claims 1
• 101000610604 Homo sapiens Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 claims 1
• 101000863873 Homo sapiens Tyrosine-protein phosphatase non-receptor type substrate 1 Proteins 0.000 claims 1
• 101000743488 Homo sapiens V-set and immunoglobulin domain-containing protein 4 Proteins 0.000 claims 1
• 101100048372 Human cytomegalovirus (strain AD169) H301 gene Proteins 0.000 claims 1
• 101100048373 Human cytomegalovirus (strain Merlin) UL18 gene Proteins 0.000 claims 1
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims 1
• 206010020751 Hypersensitivity Diseases 0.000 claims 1
• 102000037978 Immune checkpoint receptors Human genes 0.000 claims 1
• 108091008028 Immune checkpoint receptors Proteins 0.000 claims 1
• 108010034143 Inflammasomes Proteins 0.000 claims 1
• 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
• 102100037872 Intercellular adhesion molecule 2 Human genes 0.000 claims 1
• 101710148794 Intercellular adhesion molecule 2 Proteins 0.000 claims 1
• 102100026720 Interferon beta Human genes 0.000 claims 1
• 102100029838 Interferon regulatory factor 2 Human genes 0.000 claims 1
• 108090000908 Interferon regulatory factor 2 Proteins 0.000 claims 1
• 102100030126 Interferon regulatory factor 4 Human genes 0.000 claims 1
• 102100030131 Interferon regulatory factor 5 Human genes 0.000 claims 1
• 102100038069 Interferon regulatory factor 8 Human genes 0.000 claims 1
• 108010074328 Interferon-gamma Proteins 0.000 claims 1
• 102000008070 Interferon-gamma Human genes 0.000 claims 1
• 102000003814 Interleukin-10 Human genes 0.000 claims 1
• 108090000174 Interleukin-10 Proteins 0.000 claims 1
• 102100030703 Interleukin-22 Human genes 0.000 claims 1
• 108010065637 Interleukin-23 Proteins 0.000 claims 1
• 102000013264 Interleukin-23 Human genes 0.000 claims 1
• 102100039078 Interleukin-4 receptor subunit alpha Human genes 0.000 claims 1
• 102000004890 Interleukin-8 Human genes 0.000 claims 1
• 108090001007 Interleukin-8 Proteins 0.000 claims 1
• 108010002335 Interleukin-9 Proteins 0.000 claims 1
• 102000000585 Interleukin-9 Human genes 0.000 claims 1
• 101150069255 KLRC1 gene Proteins 0.000 claims 1
• 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
• 102100033599 Killer cell immunoglobulin-like receptor 2DL2 Human genes 0.000 claims 1
• 102100033634 Killer cell immunoglobulin-like receptor 2DL3 Human genes 0.000 claims 1
• 102100033630 Killer cell immunoglobulin-like receptor 2DS2 Human genes 0.000 claims 1
• 102220564757 Killer cell immunoglobulin-like receptor 2DS2_Y66F_mutation Human genes 0.000 claims 1
• 102100033627 Killer cell immunoglobulin-like receptor 3DL1 Human genes 0.000 claims 1
• 102100034840 Killer cell immunoglobulin-like receptor 3DL2 Human genes 0.000 claims 1
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
• 102000017578 LAG3 Human genes 0.000 claims 1
• FGBAVQUHSKYMTC-UHFFFAOYSA-M LDS 751 dye Chemical compound [O-]Cl(=O)(=O)=O.C1=CC2=CC(N(C)C)=CC=C2[N+](CC)=C1C=CC=CC1=CC=C(N(C)C)C=C1 FGBAVQUHSKYMTC-UHFFFAOYSA-M 0.000 claims 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 1
• 102100028047 Large proline-rich protein BAG6 Human genes 0.000 claims 1
• 108010017736 Leukocyte Immunoglobulin-like Receptor B1 Proteins 0.000 claims 1
• 108060001084 Luciferase Proteins 0.000 claims 1
• 239000005089 Luciferase Substances 0.000 claims 1
• 208000019693 Lung disease Diseases 0.000 claims 1
• 101710092458 Lymphocyte activation gene 3 protein Proteins 0.000 claims 1
• 102000001291 MAP Kinase Kinase Kinase Human genes 0.000 claims 1
• 102000043136 MAP kinase family Human genes 0.000 claims 1
• 108091054455 MAP kinase family Proteins 0.000 claims 1
• 108060006687 MAP kinase kinase kinase Proteins 0.000 claims 1
• 102100034069 MAP kinase-activated protein kinase 2 Human genes 0.000 claims 1
• 101710141394 MAP kinase-activated protein kinase 2 Proteins 0.000 claims 1
• 102100026299 MAP kinase-interacting serine/threonine-protein kinase 1 Human genes 0.000 claims 1
• 101710139011 MAP kinase-interacting serine/threonine-protein kinase 1 Proteins 0.000 claims 1
• 108700005089 MHC Class I Genes Proteins 0.000 claims 1
• 101150039798 MYC gene Proteins 0.000 claims 1
• 101100404845 Macaca mulatta NKG2A gene Proteins 0.000 claims 1
• 102100034184 Macrophage scavenger receptor types I and II Human genes 0.000 claims 1
• 102100025136 Macrosialin Human genes 0.000 claims 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
• 241000710118 Maize chlorotic mottle virus Species 0.000 claims 1
• 102100030412 Matrix metalloproteinase-9 Human genes 0.000 claims 1
• 108010023335 Member 2 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 claims 1
• 101150082854 Mertk gene Proteins 0.000 claims 1
• 206010027476 Metastases Diseases 0.000 claims 1
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 1
• 101150076359 Mhc gene Proteins 0.000 claims 1
• 102000013760 Microphthalmia-Associated Transcription Factor Human genes 0.000 claims 1
• 108010050345 Microphthalmia-Associated Transcription Factor Proteins 0.000 claims 1
• 102100031545 Microsomal triglyceride transfer protein large subunit Human genes 0.000 claims 1
• 108090000744 Mitogen-Activated Protein Kinase Kinases Proteins 0.000 claims 1
• 102000004232 Mitogen-Activated Protein Kinase Kinases Human genes 0.000 claims 1
• 102100025207 Mitogen-activated protein kinase kinase kinase 11 Human genes 0.000 claims 1
• 101000912616 Mus musculus C-type lectin domain family 2 member F Proteins 0.000 claims 1
• 101000912598 Mus musculus C-type lectin domain family 2 member H Proteins 0.000 claims 1
• 101100273740 Mus musculus Cd68 gene Proteins 0.000 claims 1
• 101100013967 Mus musculus Gata3 gene Proteins 0.000 claims 1
• 101100181101 Mus musculus Klra3 gene Proteins 0.000 claims 1
• 101100181106 Mus musculus Klra8 gene Proteins 0.000 claims 1
• 108010083674 Myelin Proteins Proteins 0.000 claims 1
• 102000006386 Myelin Proteins Human genes 0.000 claims 1
• 108010001657 NK Cell Lectin-Like Receptor Subfamily K Proteins 0.000 claims 1
• 102000000812 NK Cell Lectin-Like Receptor Subfamily K Human genes 0.000 claims 1
• 230000006051 NK cell activation Effects 0.000 claims 1
• 108091008877 NK cell receptors Proteins 0.000 claims 1
• 102000010648 Natural Killer Cell Receptors Human genes 0.000 claims 1
• 102100029527 Natural cytotoxicity triggering receptor 3 ligand 1 Human genes 0.000 claims 1
• 102100038082 Natural killer cell receptor 2B4 Human genes 0.000 claims 1
• 102100028762 Neuropilin-1 Human genes 0.000 claims 1
• PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 1
• 102000043276 Oncogene Human genes 0.000 claims 1
• 241001520191 Onychomys leucogaster Species 0.000 claims 1
• 239000012270 PD-1 inhibitor Substances 0.000 claims 1
• 239000012668 PD-1-inhibitor Substances 0.000 claims 1
• 229910019142 PO4 Inorganic materials 0.000 claims 1
• 101150042788 PROK2 gene Proteins 0.000 claims 1
• 102000035195 Peptidases Human genes 0.000 claims 1
• 108091005804 Peptidases Proteins 0.000 claims 1
• 102000007079 Peptide Fragments Human genes 0.000 claims 1
• 108010033276 Peptide Fragments Proteins 0.000 claims 1
• 108091093037 Peptide nucleic acid Proteins 0.000 claims 1
• 208000037581 Persistent Infection Diseases 0.000 claims 1
• 102000015439 Phospholipases Human genes 0.000 claims 1
• 108010064785 Phospholipases Proteins 0.000 claims 1
• 241000224016 Plasmodium Species 0.000 claims 1
• 102100033237 Pro-epidermal growth factor Human genes 0.000 claims 1
• 101800000795 Proadrenomedullin N-20 terminal peptide Proteins 0.000 claims 1
• 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 claims 1
• 102100036691 Proliferating cell nuclear antigen Human genes 0.000 claims 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 1
• OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims 1
• 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 claims 1
• 206010060862 Prostate cancer Diseases 0.000 claims 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
• 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 claims 1
• 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 claims 1
• 102000001253 Protein Kinase Human genes 0.000 claims 1
• 102000003923 Protein Kinase C Human genes 0.000 claims 1
• 108090000315 Protein Kinase C Proteins 0.000 claims 1
• 108010076504 Protein Sorting Signals Proteins 0.000 claims 1
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 claims 1
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 claims 1
• 108010067787 Proteoglycans Proteins 0.000 claims 1
• 102000016611 Proteoglycans Human genes 0.000 claims 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
• 208000009341 RNA Virus Infections Diseases 0.000 claims 1
• 108091028664 Ribonucleotide Proteins 0.000 claims 1
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims 1
• 102100033645 Ribosomal protein S6 kinase alpha-5 Human genes 0.000 claims 1
• 102100029197 SLAM family member 6 Human genes 0.000 claims 1
• 108010044012 STAT1 Transcription Factor Proteins 0.000 claims 1
• 102100025831 Scavenger receptor cysteine-rich type 1 protein M130 Human genes 0.000 claims 1
• 101100022789 Schizosaccharomyces pombe (strain 972 / ATCC 24843) med27 gene Proteins 0.000 claims 1
• 102000003800 Selectins Human genes 0.000 claims 1
• 108090000184 Selectins Proteins 0.000 claims 1
• 102000012479 Serine Proteases Human genes 0.000 claims 1
• 108010022999 Serine Proteases Proteins 0.000 claims 1
• 102100036202 Serum amyloid P-component Human genes 0.000 claims 1
• 102100029904 Signal transducer and activator of transcription 1-alpha/beta Human genes 0.000 claims 1
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
• 229930006000 Sucrose Natural products 0.000 claims 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 1
• OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 claims 1
• 101100215487 Sus scrofa ADRA2A gene Proteins 0.000 claims 1
• 208000018359 Systemic autoimmune disease Diseases 0.000 claims 1
• 230000017274 T cell anergy Effects 0.000 claims 1
• 230000037453 T cell priming Effects 0.000 claims 1
• 108010092262 T-Cell Antigen Receptors Proteins 0.000 claims 1
• 230000029662 T-helper 1 type immune response Effects 0.000 claims 1
• 210000000173 T-lymphoid precursor cell Anatomy 0.000 claims 1
• 102100036073 TIR domain-containing adapter molecule 1 Human genes 0.000 claims 1
• 101150037769 TRX2 gene Proteins 0.000 claims 1
• 229940125567 TSR-033 Drugs 0.000 claims 1
• 101800000849 Tachykinin-associated peptide 2 Proteins 0.000 claims 1
• ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims 1
• QHNORJFCVHUPNH-UHFFFAOYSA-L To-Pro-3 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=CC=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 QHNORJFCVHUPNH-UHFFFAOYSA-L 0.000 claims 1
• 108010060818 Toll-Like Receptor 9 Proteins 0.000 claims 1
• 102100039390 Toll-like receptor 7 Human genes 0.000 claims 1
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 1
• 102100027654 Transcription factor PU.1 Human genes 0.000 claims 1
• 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 claims 1
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 claims 1
• 108010040002 Tumor Suppressor Proteins Proteins 0.000 claims 1
• 102000001742 Tumor Suppressor Proteins Human genes 0.000 claims 1
• 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 claims 1
• 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims 1
• 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims 1
• 102100029948 Tyrosine-protein phosphatase non-receptor type substrate 1 Human genes 0.000 claims 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
• 102100038296 V-set and immunoglobulin domain-containing protein 4 Human genes 0.000 claims 1
• 108010003533 Viral Envelope Proteins Proteins 0.000 claims 1
• 108010067390 Viral Proteins Proteins 0.000 claims 1
• 238000002441 X-ray diffraction Methods 0.000 claims 1
• 101100459258 Xenopus laevis myc-a gene Proteins 0.000 claims 1
• XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 claims 1
• 230000002159 abnormal effect Effects 0.000 claims 1
• 238000010521 absorption reaction Methods 0.000 claims 1
• DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 claims 1
• 239000012190 activator Substances 0.000 claims 1
• 230000008649 adaptation response Effects 0.000 claims 1
• 210000005006 adaptive immune system Anatomy 0.000 claims 1
• 239000012082 adaptor molecule Substances 0.000 claims 1
• 229960000643 adenine Drugs 0.000 claims 1
• WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 claims 1
• 210000001789 adipocyte Anatomy 0.000 claims 1
• 229940072056 alginate Drugs 0.000 claims 1
• 235000010443 alginic acid Nutrition 0.000 claims 1
• 229920000615 alginic acid Polymers 0.000 claims 1
• 150000001350 alkyl halides Chemical class 0.000 claims 1
• 108010004469 allophycocyanin Proteins 0.000 claims 1
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims 1
• AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims 1
• AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
• 230000003321 amplification Effects 0.000 claims 1
• 230000036783 anaphylactic response Effects 0.000 claims 1
• 208000003455 anaphylaxis Diseases 0.000 claims 1
• 239000004037 angiogenesis inhibitor Substances 0.000 claims 1
• 229940121369 angiogenesis inhibitor Drugs 0.000 claims 1
• 238000010171 animal model Methods 0.000 claims 1
• 150000001450 anions Chemical class 0.000 claims 1
• 230000003042 antagnostic effect Effects 0.000 claims 1
• 230000001772 anti-angiogenic effect Effects 0.000 claims 1
• 238000011122 anti-angiogenic therapy Methods 0.000 claims 1
• 230000001745 anti-biotin effect Effects 0.000 claims 1
• 230000001093 anti-cancer Effects 0.000 claims 1
• 238000011224 anti-cancer immunotherapy Methods 0.000 claims 1
• 229940124650 anti-cancer therapies Drugs 0.000 claims 1
• 230000003110 anti-inflammatory effect Effects 0.000 claims 1
• 230000001775 anti-pathogenic effect Effects 0.000 claims 1
• 230000003095 anti-phagocytic effect Effects 0.000 claims 1
• 230000006023 anti-tumor response Effects 0.000 claims 1
• 238000009175 antibody therapy Methods 0.000 claims 1
• 238000011319 anticancer therapy Methods 0.000 claims 1
• 230000014102 antigen processing and presentation of exogenous peptide antigen via MHC class I Effects 0.000 claims 1
• 230000007503 antigenic stimulation Effects 0.000 claims 1
• 229940034982 antineoplastic agent Drugs 0.000 claims 1
• 239000002246 antineoplastic agent Substances 0.000 claims 1
• 230000007416 antiviral immune response Effects 0.000 claims 1
• 230000009118 appropriate response Effects 0.000 claims 1
• 210000000576 arachnoid Anatomy 0.000 claims 1
• 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 1
• 238000000149 argon plasma sintering Methods 0.000 claims 1
• 206010003246 arthritis Diseases 0.000 claims 1
• 229940009098 aspartate Drugs 0.000 claims 1
• 230000003190 augmentative effect Effects 0.000 claims 1
• 230000008267 autocrine signaling Effects 0.000 claims 1
• 229940120638 avastin Drugs 0.000 claims 1
• 230000004888 barrier function Effects 0.000 claims 1
• 150000007514 bases Chemical class 0.000 claims 1
• 230000006399 behavior Effects 0.000 claims 1
• 208000013404 behavioral symptom Diseases 0.000 claims 1
• 230000003542 behavioural effect Effects 0.000 claims 1
• 229940077388 benzenesulfonate Drugs 0.000 claims 1
• SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 claims 1
• 229940050390 benzoate Drugs 0.000 claims 1
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 1
• DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 claims 1
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
• HHJTWTPUPVQKNA-JIAPQYILSA-N beta-D-glucosylsphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HHJTWTPUPVQKNA-JIAPQYILSA-N 0.000 claims 1
• 108010005774 beta-Galactosidase Proteins 0.000 claims 1
• XMIIGOLPHOKFCH-UHFFFAOYSA-N beta-phenylpropanoic acid Natural products OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 claims 1
• 102000023732 binding proteins Human genes 0.000 claims 1
• 108091008324 binding proteins Proteins 0.000 claims 1
• 230000008827 biological function Effects 0.000 claims 1
• 239000012620 biological material Substances 0.000 claims 1
• 230000007321 biological mechanism Effects 0.000 claims 1
• 230000008512 biological response Effects 0.000 claims 1
• 230000005540 biological transmission Effects 0.000 claims 1
• 239000000090 biomarker Substances 0.000 claims 1
• 229960000074 biopharmaceutical Drugs 0.000 claims 1
• 210000004204 blood vessel Anatomy 0.000 claims 1
• 210000000988 bone and bone Anatomy 0.000 claims 1
• 210000002798 bone marrow cell Anatomy 0.000 claims 1
• 239000007853 buffer solution Substances 0.000 claims 1
• 230000000981 bystander Effects 0.000 claims 1
• 210000004899 c-terminal region Anatomy 0.000 claims 1
• DEGAKNSWVGKMLS-UHFFFAOYSA-N calcein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(O)=O)CC(O)=O)=C(O)C=C1OC1=C2C=C(CN(CC(O)=O)CC(=O)O)C(O)=C1 DEGAKNSWVGKMLS-UHFFFAOYSA-N 0.000 claims 1
• 159000000007 calcium salts Chemical class 0.000 claims 1
• 102000023852 carbohydrate binding proteins Human genes 0.000 claims 1
• 108091008400 carbohydrate binding proteins Proteins 0.000 claims 1
• 235000014633 carbohydrates Nutrition 0.000 claims 1
• 125000002843 carboxylic acid group Chemical group 0.000 claims 1
• 150000001735 carboxylic acids Chemical class 0.000 claims 1
• 239000000969 carrier Substances 0.000 claims 1
• 230000008568 cell cell communication Effects 0.000 claims 1
• 208000037887 cell injury Diseases 0.000 claims 1
• 230000004709 cell invasion Effects 0.000 claims 1
• 230000005859 cell recognition Effects 0.000 claims 1
• 230000009134 cell regulation Effects 0.000 claims 1
• 229940030156 cell vaccine Drugs 0.000 claims 1
• 230000017455 cell-cell adhesion Effects 0.000 claims 1
• 230000008614 cellular interaction Effects 0.000 claims 1
• 230000005754 cellular signaling Effects 0.000 claims 1
• 201000010881 cervical cancer Diseases 0.000 claims 1
• 229960005395 cetuximab Drugs 0.000 claims 1
• 229960005091 chloramphenicol Drugs 0.000 claims 1
• WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims 1
• 210000003483 chromatin Anatomy 0.000 claims 1
• ZYVSOIYQKUDENJ-WKSBCEQHSA-N chromomycin A3 Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@@H]1OC(C)=O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](O[C@@H]3O[C@@H](C)[C@H](OC(C)=O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1C[C@@H](O)[C@@H](OC)[C@@H](C)O1 ZYVSOIYQKUDENJ-WKSBCEQHSA-N 0.000 claims 1
• 210000000349 chromosome Anatomy 0.000 claims 1
• 230000001684 chronic effect Effects 0.000 claims 1
• 230000037326 chronic stress Effects 0.000 claims 1
• 229940001468 citrate Drugs 0.000 claims 1
• 238000003776 cleavage reaction Methods 0.000 claims 1
• 239000008119 colloidal silica Substances 0.000 claims 1
• 239000000084 colloidal system Substances 0.000 claims 1
• 210000001072 colon Anatomy 0.000 claims 1
• 238000010293 colony formation assay Methods 0.000 claims 1
• 230000001332 colony forming effect Effects 0.000 claims 1
• 230000024203 complement activation Effects 0.000 claims 1
• 239000000306 component Substances 0.000 claims 1
• 238000004883 computer application Methods 0.000 claims 1
• 238000012790 confirmation Methods 0.000 claims 1
• 238000007334 copolymerization reaction Methods 0.000 claims 1
• 230000002596 correlated effect Effects 0.000 claims 1
• 230000009260 cross reactivity Effects 0.000 claims 1
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 1
• 102000003675 cytokine receptors Human genes 0.000 claims 1
• 108010057085 cytokine receptors Proteins 0.000 claims 1
• 206010052015 cytokine release syndrome Diseases 0.000 claims 1
• 210000000805 cytoplasm Anatomy 0.000 claims 1
• 229940104302 cytosine Drugs 0.000 claims 1
• 210000004292 cytoskeleton Anatomy 0.000 claims 1
• 230000001086 cytosolic effect Effects 0.000 claims 1
• 239000003145 cytotoxic factor Substances 0.000 claims 1
• 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
• 230000003111 delayed effect Effects 0.000 claims 1
• 229940029030 dendritic cell vaccine Drugs 0.000 claims 1
• 238000000432 density-gradient centrifugation Methods 0.000 claims 1
• CFCUWKMKBJTWLW-UHFFFAOYSA-N deoliosyl-3C-alpha-L-digitoxosyl-MTM Natural products CC=1C(O)=C2C(O)=C3C(=O)C(OC4OC(C)C(O)C(OC5OC(C)C(O)C(OC6OC(C)C(O)C(C)(O)C6)C5)C4)C(C(OC)C(=O)C(O)C(C)O)CC3=CC2=CC=1OC(OC(C)C1O)CC1OC1CC(O)C(O)C(C)O1 CFCUWKMKBJTWLW-UHFFFAOYSA-N 0.000 claims 1
• 239000005547 deoxyribonucleotide Substances 0.000 claims 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 claims 1
• 238000013461 design Methods 0.000 claims 1
• 238000003745 diagnosis Methods 0.000 claims 1
• 239000000032 diagnostic agent Substances 0.000 claims 1
• 229940039227 diagnostic agent Drugs 0.000 claims 1
• 150000008050 dialkyl sulfates Chemical class 0.000 claims 1
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims 1
• 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims 1
• 238000006471 dimerization reaction Methods 0.000 claims 1
• 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims 1
• 230000003292 diminished effect Effects 0.000 claims 1
• 230000003467 diminishing effect Effects 0.000 claims 1
• XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 claims 1
• GAFRWLVTHPVQGK-UHFFFAOYSA-N dipentyl sulfate Chemical class CCCCCOS(=O)(=O)OCCCCC GAFRWLVTHPVQGK-UHFFFAOYSA-N 0.000 claims 1
• 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
• 239000002552 dosage form Substances 0.000 claims 1
• 231100000673 dose–response relationship Toxicity 0.000 claims 1
• 238000001647 drug administration Methods 0.000 claims 1
• 230000000857 drug effect Effects 0.000 claims 1
• 230000004064 dysfunction Effects 0.000 claims 1
• 230000005014 ectopic expression Effects 0.000 claims 1
• 230000002526 effect on cardiovascular system Effects 0.000 claims 1
• 230000002121 endocytic effect Effects 0.000 claims 1
• 210000001163 endosome Anatomy 0.000 claims 1
• 210000002889 endothelial cell Anatomy 0.000 claims 1
• 108010048367 enhanced green fluorescent protein Proteins 0.000 claims 1
• 239000003623 enhancer Substances 0.000 claims 1
• 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 claims 1
• 210000003386 epithelial cell of thymus gland Anatomy 0.000 claims 1
• 230000008029 eradication Effects 0.000 claims 1
• 229940082789 erbitux Drugs 0.000 claims 1
• ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 claims 1
• 229960005542 ethidium bromide Drugs 0.000 claims 1
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
• 210000003527 eukaryotic cell Anatomy 0.000 claims 1
• 230000007717 exclusion Effects 0.000 claims 1
• 239000006277 exogenous ligand Substances 0.000 claims 1
• 238000002474 experimental method Methods 0.000 claims 1
• 239000013604 expression vector Substances 0.000 claims 1
• 210000003722 extracellular fluid Anatomy 0.000 claims 1
• 230000008175 fetal development Effects 0.000 claims 1
• 210000003754 fetus Anatomy 0.000 claims 1
• 229960004177 filgrastim Drugs 0.000 claims 1
• 238000005206 flow analysis Methods 0.000 claims 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims 1
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims 1
• 108091006047 fluorescent proteins Proteins 0.000 claims 1
• 102000034287 fluorescent proteins Human genes 0.000 claims 1
• 238000009472 formulation Methods 0.000 claims 1
• 238000013467 fragmentation Methods 0.000 claims 1
• 238000006062 fragmentation reaction Methods 0.000 claims 1
• 239000012458 free base Substances 0.000 claims 1
• 125000000524 functional group Chemical group 0.000 claims 1
• 230000006251 gamma-carboxylation Effects 0.000 claims 1
• 238000012239 gene modification Methods 0.000 claims 1
• 230000008303 genetic mechanism Effects 0.000 claims 1
• 230000005017 genetic modification Effects 0.000 claims 1
• 235000013617 genetically modified food Nutrition 0.000 claims 1
• 210000001102 germinal center b cell Anatomy 0.000 claims 1
• 229930195712 glutamate Natural products 0.000 claims 1
• 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 claims 1
• 150000004676 glycans Chemical class 0.000 claims 1
• 150000002339 glycosphingolipids Chemical class 0.000 claims 1
• 230000013595 glycosylation Effects 0.000 claims 1
• 238000006206 glycosylation reaction Methods 0.000 claims 1
• 208000024908 graft versus host disease Diseases 0.000 claims 1
• 150000004820 halides Chemical class 0.000 claims 1
• 230000035876 healing Effects 0.000 claims 1
• 230000011132 hemopoiesis Effects 0.000 claims 1
• 229920000669 heparin Polymers 0.000 claims 1
• 229960002897 heparin Drugs 0.000 claims 1
• 210000003494 hepatocyte Anatomy 0.000 claims 1
• MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 claims 1
• 229940022353 herceptin Drugs 0.000 claims 1
• 125000000623 heterocyclic group Chemical group 0.000 claims 1
• FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
• 230000002962 histologic effect Effects 0.000 claims 1
• 239000000710 homodimer Substances 0.000 claims 1
• 229920001519 homopolymer Polymers 0.000 claims 1
• 230000005745 host immune response Effects 0.000 claims 1
• 102000055177 human KIR3DS1 Human genes 0.000 claims 1
• 210000005260 human cell Anatomy 0.000 claims 1
• 230000028996 humoral immune response Effects 0.000 claims 1
• 230000008348 humoral response Effects 0.000 claims 1
• 235000003642 hunger Nutrition 0.000 claims 1
• 210000004754 hybrid cell Anatomy 0.000 claims 1
• XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims 1
• ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims 1
• QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 claims 1
• 230000007062 hydrolysis Effects 0.000 claims 1
• 238000006460 hydrolysis reaction Methods 0.000 claims 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
• 230000033444 hydroxylation Effects 0.000 claims 1
• 238000005805 hydroxylation reaction Methods 0.000 claims 1
• 229960003685 imatinib mesylate Drugs 0.000 claims 1
• YLMAHDNUQAMNNX-UHFFFAOYSA-N imatinib methanesulfonate Chemical compound CS(O)(=O)=O.C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 YLMAHDNUQAMNNX-UHFFFAOYSA-N 0.000 claims 1
• 230000005934 immune activation Effects 0.000 claims 1
• 229940126546 immune checkpoint molecule Drugs 0.000 claims 1
• 230000036737 immune function Effects 0.000 claims 1
• 230000032832 immune response to tumor cell Effects 0.000 claims 1
• 229940072221 immunoglobulins Drugs 0.000 claims 1
• 210000000428 immunological synapse Anatomy 0.000 claims 1
• 230000002434 immunopotentiative effect Effects 0.000 claims 1
• 210000005008 immunosuppressive cell Anatomy 0.000 claims 1
• 230000001024 immunotherapeutic effect Effects 0.000 claims 1
• 230000003116 impacting effect Effects 0.000 claims 1
• 230000006872 improvement Effects 0.000 claims 1
• 239000000411 inducer Substances 0.000 claims 1
• 229940060367 inert ingredients Drugs 0.000 claims 1
• 239000012678 infectious agent Substances 0.000 claims 1
• 230000004968 inflammatory condition Effects 0.000 claims 1
• 230000037456 inflammatory mechanism Effects 0.000 claims 1
• 230000004941 influx Effects 0.000 claims 1
• 238000002329 infrared spectrum Methods 0.000 claims 1
• 239000004615 ingredient Substances 0.000 claims 1
• 229960000367 inositol Drugs 0.000 claims 1
• 229940079322 interferon Drugs 0.000 claims 1
• 229960003130 interferon gamma Drugs 0.000 claims 1
• 229940047124 interferons Drugs 0.000 claims 1
• 229940076144 interleukin-10 Drugs 0.000 claims 1
• 230000018711 interleukin-13 production Effects 0.000 claims 1
• 108010074108 interleukin-21 Proteins 0.000 claims 1
• 210000000936 intestine Anatomy 0.000 claims 1
• 230000004068 intracellular signaling Effects 0.000 claims 1
• 230000002601 intratumoral effect Effects 0.000 claims 1
• 238000011835 investigation Methods 0.000 claims 1
• 150000002500 ions Chemical class 0.000 claims 1
• 229960005386 ipilimumab Drugs 0.000 claims 1
• 230000002427 irreversible effect Effects 0.000 claims 1
• SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 claims 1
• 238000005304 joining Methods 0.000 claims 1
• 238000002372 labelling Methods 0.000 claims 1
• 210000001821 langerhans cell Anatomy 0.000 claims 1
• 230000002045 lasting effect Effects 0.000 claims 1
• 230000003902 lesion Effects 0.000 claims 1
• 208000032839 leukemia Diseases 0.000 claims 1
• 230000021633 leukocyte mediated immunity Effects 0.000 claims 1
• 108010053156 lipid transfer protein Proteins 0.000 claims 1
• 230000033001 locomotion Effects 0.000 claims 1
• 230000007774 longterm Effects 0.000 claims 1
• 231100000053 low toxicity Toxicity 0.000 claims 1
• DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 claims 1
• 210000000207 lymphocyte subset Anatomy 0.000 claims 1
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
• 150000002680 magnesium Chemical class 0.000 claims 1
• 229910052749 magnesium Inorganic materials 0.000 claims 1
• 239000011777 magnesium Substances 0.000 claims 1
• 238000007885 magnetic separation Methods 0.000 claims 1
• 239000011976 maleic acid Substances 0.000 claims 1
• 238000007726 management method Methods 0.000 claims 1
• 238000012083 mass cytometry Methods 0.000 claims 1
• 238000001819 mass spectrum Methods 0.000 claims 1
• 238000005259 measurement Methods 0.000 claims 1
• 239000002609 medium Substances 0.000 claims 1
• 238000002844 melting Methods 0.000 claims 1
• 230000008018 melting Effects 0.000 claims 1
• 102000006240 membrane receptors Human genes 0.000 claims 1
• 108020004084 membrane receptors Proteins 0.000 claims 1
• 210000001806 memory b lymphocyte Anatomy 0.000 claims 1
• 230000037353 metabolic pathway Effects 0.000 claims 1
• 230000006609 metabolic stress Effects 0.000 claims 1
• 239000002207 metabolite Substances 0.000 claims 1
• 230000009401 metastasis Effects 0.000 claims 1
• 230000001394 metastastic effect Effects 0.000 claims 1
• 206010061289 metastatic neoplasm Diseases 0.000 claims 1
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 claims 1
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
• 239000010445 mica Substances 0.000 claims 1
• 229910052618 mica group Inorganic materials 0.000 claims 1
• 108010038232 microsomal triglyceride transfer protein Proteins 0.000 claims 1
• 150000007522 mineralic acids Chemical class 0.000 claims 1
• 231100000324 minimal toxicity Toxicity 0.000 claims 1
• CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 claims 1
• 239000003226 mitogen Substances 0.000 claims 1
• 229960004857 mitomycin Drugs 0.000 claims 1
• 230000009456 molecular mechanism Effects 0.000 claims 1
• 230000003990 molecular pathway Effects 0.000 claims 1
• 238000012544 monitoring process Methods 0.000 claims 1
• SUIPVTCEECPFIB-UHFFFAOYSA-N monochlorobimane Chemical compound ClCC1=C(C)C(=O)N2N1C(C)=C(C)C2=O SUIPVTCEECPFIB-UHFFFAOYSA-N 0.000 claims 1
• 210000002864 mononuclear phagocyte Anatomy 0.000 claims 1
• 230000000877 morphologic effect Effects 0.000 claims 1
• 238000010172 mouse model Methods 0.000 claims 1
• 210000003205 muscle Anatomy 0.000 claims 1
• 210000005012 myelin Anatomy 0.000 claims 1
• 210000004479 myeloid suppressor cell Anatomy 0.000 claims 1
• 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
• KVBGVZZKJNLNJU-UHFFFAOYSA-M naphthalene-2-sulfonate Chemical compound C1=CC=CC2=CC(S(=O)(=O)[O-])=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-M 0.000 claims 1
• 230000031990 negative regulation of inflammatory response Effects 0.000 claims 1
• 229940029345 neupogen Drugs 0.000 claims 1
• 230000001537 neural effect Effects 0.000 claims 1
• 230000007135 neurotoxicity Effects 0.000 claims 1
• 231100000228 neurotoxicity Toxicity 0.000 claims 1
• 235000001968 nicotinic acid Nutrition 0.000 claims 1
• 239000011664 nicotinic acid Substances 0.000 claims 1
• 238000006396 nitration reaction Methods 0.000 claims 1
• 229910052757 nitrogen Inorganic materials 0.000 claims 1
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
• 239000001272 nitrous oxide Substances 0.000 claims 1
• 229960003301 nivolumab Drugs 0.000 claims 1
• SJYNFBVQFBRSIB-UHFFFAOYSA-N norbornadiene Chemical compound C1=CC2C=CC1C2 SJYNFBVQFBRSIB-UHFFFAOYSA-N 0.000 claims 1
• 210000000633 nuclear envelope Anatomy 0.000 claims 1
• 238000000655 nuclear magnetic resonance spectrum Methods 0.000 claims 1
• 238000003199 nucleic acid amplification method Methods 0.000 claims 1
• 210000004940 nucleus Anatomy 0.000 claims 1
• 229960002378 oftasceine Drugs 0.000 claims 1
• 238000006384 oligomerization reaction Methods 0.000 claims 1
• 230000000174 oncolytic effect Effects 0.000 claims 1
• 210000003463 organelle Anatomy 0.000 claims 1
• 235000005985 organic acids Nutrition 0.000 claims 1
• 235000006408 oxalic acid Nutrition 0.000 claims 1
• PIRWNASAJNPKHT-SHZATDIYSA-N pamp Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)N)C(C)C)C1=CC=CC=C1 PIRWNASAJNPKHT-SHZATDIYSA-N 0.000 claims 1
• 210000000496 pancreas Anatomy 0.000 claims 1
• 230000014306 paracrine signaling Effects 0.000 claims 1
• 244000045947 parasite Species 0.000 claims 1
• 230000024241 parasitism Effects 0.000 claims 1
• 230000036961 partial effect Effects 0.000 claims 1
• 229940121655 pd-1 inhibitor Drugs 0.000 claims 1
• 229960002621 pembrolizumab Drugs 0.000 claims 1
• 150000002972 pentoses Chemical class 0.000 claims 1
• 108010082406 peptide permease Proteins 0.000 claims 1
• JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 claims 1
• 210000001986 peyer's patch Anatomy 0.000 claims 1
• 210000001539 phagocyte Anatomy 0.000 claims 1
• 239000008177 pharmaceutical agent Substances 0.000 claims 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
• 239000010452 phosphate Substances 0.000 claims 1
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 1
• 150000003904 phospholipids Chemical class 0.000 claims 1
• 229910052698 phosphorus Inorganic materials 0.000 claims 1
• 230000004962 physiological condition Effects 0.000 claims 1
• 230000035790 physiological processes and functions Effects 0.000 claims 1
• INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 claims 1
• 229940075930 picrate Drugs 0.000 claims 1
• OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 claims 1
• 229950010765 pivalate Drugs 0.000 claims 1
• IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 claims 1
• 239000013612 plasmid Substances 0.000 claims 1
• 210000004180 plasmocyte Anatomy 0.000 claims 1
• 229960003171 plicamycin Drugs 0.000 claims 1
• 229920001282 polysaccharide Polymers 0.000 claims 1
• 239000005017 polysaccharide Substances 0.000 claims 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
• 230000033294 positive regulation of MAPK cascade Effects 0.000 claims 1
• 230000001323 posttranslational effect Effects 0.000 claims 1
• 150000003141 primary amines Chemical class 0.000 claims 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
• 230000000861 pro-apoptotic effect Effects 0.000 claims 1
• 238000004393 prognosis Methods 0.000 claims 1
• 230000002062 proliferating effect Effects 0.000 claims 1
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
• 210000002307 prostate Anatomy 0.000 claims 1
• 230000001681 protective effect Effects 0.000 claims 1
• 108060006633 protein kinase Proteins 0.000 claims 1
• 230000002797 proteolythic effect Effects 0.000 claims 1
• 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 claims 1
• 108010008929 proto-oncogene protein Spi-1 Proteins 0.000 claims 1
• 230000002685 pulmonary effect Effects 0.000 claims 1
• 150000003230 pyrimidines Chemical class 0.000 claims 1
• 230000005855 radiation Effects 0.000 claims 1
• 230000005258 radioactive decay Effects 0.000 claims 1
• 108010014186 ras Proteins Proteins 0.000 claims 1
• 102000016914 ras Proteins Human genes 0.000 claims 1
• 239000007845 reactive nitrogen species Substances 0.000 claims 1
• 230000002829 reductive effect Effects 0.000 claims 1
• 230000001172 regenerating effect Effects 0.000 claims 1
• 230000014176 regulation of innate immune response Effects 0.000 claims 1
• 230000013065 regulation of toll-like receptor signaling pathway Effects 0.000 claims 1
• 230000008521 reorganization Effects 0.000 claims 1
• 230000010076 replication Effects 0.000 claims 1
• 230000003362 replicative effect Effects 0.000 claims 1
• 210000002345 respiratory system Anatomy 0.000 claims 1
• 230000008458 response to injury Effects 0.000 claims 1
• 230000000284 resting effect Effects 0.000 claims 1
• 239000002336 ribonucleotide Substances 0.000 claims 1
• 125000002652 ribonucleotide group Chemical group 0.000 claims 1
• 210000003935 rough endoplasmic reticulum Anatomy 0.000 claims 1
• 102200071196 rs1800730 Human genes 0.000 claims 1
• 102200089551 rs5030826 Human genes 0.000 claims 1
• 102200089550 rs869025616 Human genes 0.000 claims 1
• 230000007017 scission Effects 0.000 claims 1
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims 1
• 150000003335 secondary amines Chemical class 0.000 claims 1
• 238000010187 selection method Methods 0.000 claims 1
• DYPYMMHZGRPOCK-UHFFFAOYSA-N seminaphtharhodafluor Chemical compound O1C(=O)C2=CC=CC=C2C21C(C=CC=1C3=CC=C(O)C=1)=C3OC1=CC(N)=CC=C21 DYPYMMHZGRPOCK-UHFFFAOYSA-N 0.000 claims 1
• 230000035807 sensation Effects 0.000 claims 1
• 238000000926 separation method Methods 0.000 claims 1
• 230000009919 sequestration Effects 0.000 claims 1
• 210000002966 serum Anatomy 0.000 claims 1
• 102000035025 signaling receptors Human genes 0.000 claims 1
• 108091005475 signaling receptors Proteins 0.000 claims 1
• 229940126586 small molecule drug Drugs 0.000 claims 1
• 150000003384 small molecules Chemical class 0.000 claims 1
• AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 claims 1
• 239000007787 solid Substances 0.000 claims 1
• 230000000392 somatic effect Effects 0.000 claims 1
• 210000000278 spinal cord Anatomy 0.000 claims 1
• 230000002269 spontaneous effect Effects 0.000 claims 1
• 238000007619 statistical method Methods 0.000 claims 1
• 210000001562 sternum Anatomy 0.000 claims 1
• 239000000758 substrate Substances 0.000 claims 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 1
• 239000001384 succinic acid Substances 0.000 claims 1
• 239000005720 sucrose Substances 0.000 claims 1
• 230000019635 sulfation Effects 0.000 claims 1
• 238000005670 sulfation reaction Methods 0.000 claims 1
• 239000001117 sulphuric acid Substances 0.000 claims 1
• 235000011149 sulphuric acid Nutrition 0.000 claims 1
• 238000010897 surface acoustic wave method Methods 0.000 claims 1
• 239000000725 suspension Substances 0.000 claims 1
• 230000002459 sustained effect Effects 0.000 claims 1
• 208000011580 syndromic disease Diseases 0.000 claims 1
• 238000003786 synthesis reaction Methods 0.000 claims 1
• 229920002994 synthetic fiber Polymers 0.000 claims 1
• 238000010189 synthetic method Methods 0.000 claims 1
• 230000009885 systemic effect Effects 0.000 claims 1
• 229960001603 tamoxifen Drugs 0.000 claims 1
• 108010059434 tapasin Proteins 0.000 claims 1
• 238000002626 targeted therapy Methods 0.000 claims 1
• 229940095064 tartrate Drugs 0.000 claims 1
• 150000003512 tertiary amines Chemical class 0.000 claims 1
• 238000012360 testing method Methods 0.000 claims 1
• CBXCPBUEXACCNR-UHFFFAOYSA-N tetraethylammonium Chemical compound CC[N+](CC)(CC)CC CBXCPBUEXACCNR-UHFFFAOYSA-N 0.000 claims 1
• QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 claims 1
• JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 claims 1
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 claims 1
• 229940021747 therapeutic vaccine Drugs 0.000 claims 1
• 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
• 229940113082 thymine Drugs 0.000 claims 1
• 230000000451 tissue damage Effects 0.000 claims 1
• 231100000827 tissue damage Toxicity 0.000 claims 1
• 230000017423 tissue regeneration Effects 0.000 claims 1
• 230000007838 tissue remodeling Effects 0.000 claims 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 1
• 230000002463 transducing effect Effects 0.000 claims 1
• 230000009466 transformation Effects 0.000 claims 1
• 238000012250 transgenic expression Methods 0.000 claims 1
• 230000001052 transient effect Effects 0.000 claims 1
• 230000007704 transition Effects 0.000 claims 1
• 238000013519 translation Methods 0.000 claims 1
• 108091007466 transmembrane glycoproteins Proteins 0.000 claims 1
• 229960000575 trastuzumab Drugs 0.000 claims 1
• 230000001960 triggered effect Effects 0.000 claims 1
• 230000001228 trophic effect Effects 0.000 claims 1
• 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 claims 1
• 230000005747 tumor angiogenesis Effects 0.000 claims 1
• 230000004565 tumor cell growth Effects 0.000 claims 1
• 230000005748 tumor development Effects 0.000 claims 1
• 102000003298 tumor necrosis factor receptor Human genes 0.000 claims 1
• 210000000037 type II NK T lymphocyte Anatomy 0.000 claims 1
• 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
• 238000010798 ubiquitination Methods 0.000 claims 1
• 230000034512 ubiquitination Effects 0.000 claims 1
• 238000002211 ultraviolet spectrum Methods 0.000 claims 1
• 231100000402 unacceptable toxicity Toxicity 0.000 claims 1
• 230000004222 uncontrolled growth Effects 0.000 claims 1
• ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 claims 1
• 230000003827 upregulation Effects 0.000 claims 1
• 229940035893 uracil Drugs 0.000 claims 1
• 201000005112 urinary bladder cancer Diseases 0.000 claims 1
• 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
• 239000012808 vapor phase Substances 0.000 claims 1
• 239000003981 vehicle Substances 0.000 claims 1
• 210000003462 vein Anatomy 0.000 claims 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
• 230000029663 wound healing Effects 0.000 claims 1